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Abstract 
Validating a Procedure to Assess Declines in Acute Cigarette  
Self-Administration due to Reductions in Nicotine Content 
 
Joshua Lee Karelitz, PhD 
 
University of Pittsburgh, 2019 
 
 
 
 
The FDA has considered reducing the maximum allowable nicotine content in cigarettes 
to facilitate quitting in dependent smokers. To potentially inform clinical research on nicotine 
reduction, this laboratory-based study used a within-subjects forced-choice paradigm to assess 
dose-related declines in relative nicotine reinforcement in dependent adult smokers (N=37). The 
aim was to establish the clinically predictive validity of this paradigm by relating findings to results 
from the Donny et al. (2015) clinical trial on smoking reduction with reduced nicotine cigarettes. 
In five sessions following overnight abstinence, SPECTRUM research cigarettes varying in 
nicotine contents (17.4, 11.2, 5.5, 2.3, and 1.3 mg/g; one “NIC” dose per session), were compared 
to a very low nicotine content cigarette (“VLNC”; 0.4 mg/g). Each session began with four 4-puff 
exposure trials (2 each NIC or VLNC, identified by letter codes). Assessment of pleasurable 
sensory perceptions of smoking occurred immediately following each exposure trial. Next were 
four choice trials in which NIC and VLNC cigarettes were presented concurrently; participants 
were instructed to take four puffs from any combination of the cigarettes they wanted, totaling 16 
choices. Overall, the number of NIC choices and the magnitude of difference in pleasurable 
sensory perceptions (NIC – VLNC) increased significantly as the nicotine content condition 
increased. Sensory responses were found to mediate the relationship between nicotine content 
condition and choice. Differences in choice and sensory responses due to menthol preference 
and/or ethnicity were also found. However, the pattern NIC choices across nicotine content 
 v 
conditions were not consistent with the pattern of results observed by Donny et al. (2015), failing 
to establish clinically predictive validity of the forced choice procedure. Although this within-
subjects acute choice procedure did not closely relate to the between-subjects ad lib smoking 
behavior across weeks in Donny et al., this procedure may combine with other data to suggest a 
nicotine reduction to ≤2.3 mg/g may attenuate reinforcement. 
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1.0 Introduction 
Despite a steady decrease in prevalence over the decades following the 1964 United States 
Surgeon General’s Report (U.S. Department of Health and Human Services [USDHHS], 1964), 
tobacco smoking remains a public health crisis in the United States (US). Smoking prevalence 
among US adults (≥18 years) has continued to decline in the 21st century—20.9% in 2005 to 
14.0% in 2017—but there are still 34.3 million daily cigarette smokers (Wang et al., 2018), and 
smoking remains the leading cause of preventable mortality in the US, responsible for 480,000 
deaths every year (USDHHS, 2014). Action is needed to further reduce the prevalence of tobacco 
smoking and lessen its burden on public health. 
Nicotine is the primary reinforcing constituent in tobacco, largely responsible for initiation 
and maintenance of smoking behavior (Rupprecht, Smith, Schassburger, Buffalari, Sved, & 
Donny, 2015; USDHHS, 2014). To mitigate harm from tobacco smoking, the US Food and Drug 
Administration (FDA) is considering regulation to reduce nicotine content in cigarettes (FDA, 
2018). One goal of this proposed regulation is to reduce the nicotine content in cigarettes to a level 
that would make it easier for established smokers to quit (Benowitz & Henningfield, 1994, 2013, 
2018). For context, nicotine contents of the 100 most popular cigarette brands sold in the United 
States range 13.2 to 29.3 milligrams of nicotine per gram of tobacco filler (mg/g), with an average 
of 17.2 mg/g (Carmines & Gillman, 2019). Research is needed to identify how much of a nicotine 
reduction is needed to meet the FDA’s goal and provide the public health justification for 
establishing that new nicotine standard (FDA, 2018). For example, if the maximum nicotine 
content is set too high, established smokers may continue to struggle with quitting; if set too low, 
smokers may not find the products acceptable (even if they make quitting easier), which may 
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promote a black market for cigarettes containing higher levels of nicotine (Berman, Zettler, & 
Ashley, 2018). 
The most compelling data to date—providing support for the potential efficacy of a 
nicotine reduction policy in reducing tobacco-related harm—comes from a multi-site randomized 
controlled clinical trial conducted by Donny and colleagues (2015). In their seminal study, Donny 
et al. assessed smoking reduction in different groups after switching exposure to one level of 
nicotine content cigarettes (15.8, 5.2, 2.4, 1.3, or 0.4 mg nicotine per gram of tobacco) across six 
weeks of use in the natural environment. At the end of the study, mean cigarettes smoked per day 
was similar between the 15.8 and 5.2 mg/g groups, but groups assigned to contents ≤2.4 mg/g 
smoked significantly fewer cigarettes per day than those in the 15.8 and 5.2 mg/g groups (Donny 
et al., 2015). In other words, reducing nicotine content in cigarettes to levels ≤2.4 mg/g led to 
significant declines in self-administration, relative to the 15.8 mg/g cigarette (i.e. that containing 
a nicotine level typically found in commercial brand cigarettes).  
Large-scale randomized controlled clinical trials are often regarded as the ideal source for 
data used to determine the safety and efficacy of novel interventions (Frieden, 2017; Houle, 2015; 
Tunis, Stryer, & Clancy, 2003), such as the investigational tobacco products examined in Donny 
et al. (2015). There are many strengths inherent to this methodology (Frieden, 2017; Houle, 2015). 
For example, randomizing participants to treatment groups minimizes risk of biased results by 
equally distributing known and unknown potential confounding variables between groups. Also, 
use of a control—typically a placebo or usual treatment—allows for better identification of causal 
relationships. Despite these methodological strengths, randomized controlled trials are resource 
intensive; these studies typically require large sample sizes, are expensive, and often take many 
years to plan, implement, and complete (Frieden, 2017).  
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Shorter-term, lab-based studies may be able to provide similarly valid evidence and inform 
new clinical trial designs (Frieden, 2017; Tunis, Stryer, & Clancy, 2003). In the context of the 
present study, a lab-based paradigm assessing relative reinforcement of nicotine across a range of 
doses may be sensitive enough to identify the reduction in nicotine content needed to detect 
significant declines in relative reinforcement (used here as an index of cigarette self-
administration), somewhat similar to the measure of self-administration examined by Donny et al. 
(2015). If shown to have such predictive validity, a lab-based within-subjects study, requiring a 
much smaller sample (and thus shorter and more feasible), could be used to inform design of such 
trials.  
On the other hand, it is not yet clear whether results from lab-based studies of acute relative 
reinforcement could directly inform design of longer-term clinical trials. There is an underlying 
assumption that these different research designs would yield comparable results despite divergent 
methods. To test this assumption, Katz (1990) proposed that the predictive ability of a relative 
reinforcement paradigm can be validated by relating its results to actual drug use data. Earlier 
studies have tried to relate results of such lab-based studies of various drugs to indirect clinical 
evidence from epidemiological survey data, with mixed results—most likely due to a lack of 
specificity when assessing amount of drug use in the epidemiological data (Katz, 1990). As Katz 
stated, a better way to establish the predictive validity of an acute lab-based study of relative 
reinforcement would be to more directly test against results of a clinical trial assessing rates of use 
for those same drug doses over an extended period of time. This validation approach would rely 
on assessments of actual drug use rather than broad epidemiological measures used in earlier 
studies.  
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The current study aims to establish the predictive validity of a within-subjects lab-based 
procedure in determining how much of a decline in nicotine content is needed to significantly 
reduce acute relative reinforcing effects of nicotine. Specifically, I aim to show that differences in 
acute reinforcement due to changes in cigarettes’ nicotine content will be predictive of patterns of 
self-administration observed in extended clinical study of these cigarettes. To stringently test the 
clinical implications of this acute lab test, results will be judged valid if consistent with Donny et 
al. (2015): cigarettes containing <5 mg/g of nicotine will significantly reduce choice (indexing 
self-administration) relative to that typical of nicotine found in commercially available cigarettes, 
represented here by one with 17.4 mg/g (Carmines & Gillman, 2019). Described in greater detail 
below, the within-subjects choice paradigm used in the current study, with its focus on preference 
between nicotine contents rather than amount of ad lib consumption from each content (as in 
Donny et al., 2015), may be more sensitive to differences between contents (Perkins, Jacobs, 
Sanders, & Caggiula, 2002; Shahan, Bickel, Madden, & Badger, 1999).  
In the upcoming sections, I will provide a description of recently developed reduced 
nicotine content (RNC) research cigarettes, followed by a detailed review of Donny and 
colleagues’ clinical trial of these RNC cigarettes. Finally, I will describe commonly used methods 
to assess acute nicotine reinforcement and how they potentially could be used to assess dose-
response effects consistent with smoking behavior measured by Donny et al. (2015), ending with 
a description of the “forced choice” procedure employed in this validity study. 
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1.1 Reduced Nicotine Content Cigarettes 
Reduced nicotine content (RNC) cigarettes were designed to manipulate nicotine content 
in the tobacco, to better control how much nicotine is delivered via smoking, compared to 
previously available “light” or “ultra-light” commercial cigarettes, which manipulated nicotine 
“yield”. Nicotine yield is the amount of nicotine in smoke extracted from a cigarette via smoke 
machines designed to draw a standardized amount of smoke from the cigarette being tested 
(Pillsbury, 1996). So-called “light” or “ultra-light” commercial cigarettes were able to alter 
nicotine yield assessed by the machines through filter ventilation holes or other design aspects 
(Kozlowski et al., 1994; 2002). However, unlike smoke machines, human smokers can change 
their smoking behavior (e.g., take deeper puffs, cover ventilation holes, etc.) to alter the resulting 
nicotine intake despite a fixed nicotine content in the cigarette, reducing the validity of yield as a 
measure for assessing nicotine delivery (Kozlowski et al., 1994; 2002). With RNC cigarettes, by 
contrast, smokers cannot easily alter smoking behavior to extract higher levels of nicotine 
(Benowitz et al., 2012; Kamens et al., 2019), allowing studies using RNC cigarettes to better 
evaluate dose-response effects due to nicotine via tobacco smoke.  
SPECTRUM RNC cigarettes were made available for use in research through the NIDA 
Nicotine Research Cigarettes Drug Supply Program (https://www.drugabuse.gov/nicotine-
research-cigarette-drug-supply-program). These SPECTRUM cigarettes are matched on non-
nicotine factors (e.g., branding, paper and filter characteristics, etc.) but differ in the nicotine 
content of the tobacco they contain (Richter et al., 2016). The nicotine content is determined by 
mixing varying ratios of conventional nicotine tobacco and tobacco that has been genetically 
altered and bred to produce low levels of nicotine. The lowest nicotine content SPECTRUM 
cigarette (0.4 mg/g) contains only the low level nicotine tobacco, the highest content (15.8-17.4 
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mg/g, varies by batch) contains only the conventional nicotine level tobacco, and the levels 
between (i.e., 1.3-11.2 mg/g) contain varying blends needed to obtain the target nicotine content 
(Carmines & Gillman, 2019; Richter et al., 2016). 
1.2 Randomized Trial of Reduced-Nicotine Standards for Cigarettes 
Donny and colleagues (2015) conducted the first large-scale clinical trial of SPECTRUM 
cigarettes to assess changes in smoking behavior due to extended use of cigarettes containing 
moderate to low amounts of nicotine. Results of this trial were intended to provide an empirical 
foundation to guide potential regulation limiting nicotine content in cigarettes. Eight hundred and 
forty participants—healthy adult smokers recruited across ten sites nationwide—were randomized 
to exclusively use one level of SPECTRUM cigarettes for the six-week study period: a control 
cigarette containing 15.8 mg/g (the conventional nicotine level available in SPECTRUM cigarettes 
at the time), and cigarettes containing lower levels of nicotine: 5.2, 2.4, 1.3, 0.4 mg/g, or 0.4 mg/g 
with high tar. All SPECTRUM cigarettes were provided free of charge and in double-blind fashion.  
The primary dependent measure was self-reported number of cigarettes smoked in the prior 
day, reported through a phone-based interactive voice-response (IVR) system where participants 
used a telephone keypad to respond to verbal prompts. Additional measures of nicotine 
dependence, biomarkers of nicotine exposure, and 24-hour abstinence-induced withdrawal 
symptoms were collected in at least one of ten lab visits. At the end of the six-week study, 
participants assigned to contents ≤2.4 mg/g smoked significantly fewer cigarettes per day 
compared to the 15.8 mg/g group, thus, demonstrating cigarettes containing ≤2.4 mg/g are less 
reinforcing than those with contents similar to brands currently available commercially. Additional 
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measures obtained at week 6 indicated significantly lower levels of total urinary nicotine 
equivalents, nicotine dependence, and magnitude of withdrawal symptoms when 24-hrs abstinent 
for groups ≤2.4 vs 15.8 mg/g. Taken together, reducing nicotine content in cigarettes from 15.8 to 
≤2.4 mg/g reduced self-administration (as assessed with self-reported cigs/day and biomarkers of 
nicotine exposure) and nicotine dependence without increasing withdrawal-related discomfort 
when abstinent.   
Results of Donny et al. (2015) provide compelling evidence that reducing the nicotine 
content in cigarettes to levels at or below 2.4 mg/g will lead to reductions in cigarette consumption 
in healthy adult smokers. One possible limitation was the use of IVR to assess cigarettes smoked 
in the previous day. Despite the recency of the smoking behavior being reported, retrospective 
recall of cigarette consumption has been shown to be affected by digit bias or “heaping”, where 
participants round to multiples of 5’s or 10’s (Griffith, Shiffman, & Heitjan, 2009; Shiffman, 2009; 
Wang & Heitjan, 2008; Wang, Shiffman, Griffith, & Heitjan, 2012). Indeed, inspection of the data 
from Donny et al. (2015) show that groups clustered around 15 or 20 cigarettes per day at week 
six. Similar studies have used ecological momentary assessment or collected all smoked cigarette 
butts to corroborate IVR measures of cigarette consumption (Mercincavage et al., 2016, 2018; 
Shiffman et al., 2018). Direct observation of all smoking would be one way to objectively assess 
smoking exposure, but this approach might not be feasible in a clinical trial. In contrast, smoking 
would be able to be directly observed and objectively measured in a short-term lab-based study 
assessing declines in self-administration due to changes in cigarettes’ nicotine content. In the 
following section, I will discuss commonly used lab-based self-administration research methods 
which may be able to detect changes in smoking behavior due to reductions in nicotine content. 
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1.3 Acute Self-Administration Research Methods 
Self-administration studies are recognized as the gold standard for assessing drug 
reinforcement (Bozarth, 1987; Henningfield & Goldberg, 1983; Jones & Comer, 2013; Rupprecht 
et al., 2015; Sofuoglu & LeSage, 2012). Broadly, self-administration studies measure how much 
drug an individual consumes (MacKillop & Murphy, 2013). For a drug to be considered 
reinforcing, it must be self-administered to a greater degree than a vehicle or placebo (Higgins & 
Hughes, 1998; Sofuoglu & LeSage, 2012). Here, reinforcement is used to describe the relationship 
between behavior (i.e., drug use) and consequences of that behavior (i.e., increasing likelihood of 
further drug use; Bozarth, 1987). This behavioral definition of reinforcement does not rely on 
subjective perceptions of a drug’s effects (e.g., ‘liking’, ‘wanting’, ‘satisfying’, etc.) to determine 
its magnitude of reinforcement. There are a variety of paradigms used in self-administration 
research (Bozarth, 1987; Carter et al., 2009; Higgins & Hughes, 1998; MacKillop & Murphy, 
2013); those most relevant to the current project will be identified and discussed below, followed 
by review of a study using these methods to assess differences in smoking behavior using 
SPECTRUM cigarettes in a narrow sample of smokers.  
1.3.1  Self-administration paradigms 
Commonly used methods for assessing nicotine reinforcement in self-administration 
research include free choice, operant response, and forced choice procedures (Bozarth, 1987; 
Carter et al., 2009; Higgins & Hughes, 1998; MacKillop & Murphy, 2013). A number of methods 
are common across these paradigms, including within-subjects designs, requiring fewer 
participants to achieve adequate statistical power to detect an effect relative to between-subjects 
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designs (Carter et al., 2009; Cohen, 1988). Because self-administration of one dose is compared 
to self-administration of a placebo or another dose, participants typically first sample each 
available option, either in the same or preceding sessions (Carter et al., 2009). Initial exposures to 
each dose are necessary to familiarize participants with each available option to inform subsequent 
self-administration behavior. In clinical studies, doses are often presented in single- or double-
blind fashion and are identified by either a letter, number, or color code to maintain blinding to 
dose (de Wit & Johanson, 1987; Duke, Johnson, Reissig, & Griffiths, 2015; Perkins et al., 1994, 
1996, 2017a, 2018; Rukstalis et al., 2005). Also, participants are commonly required to abstain 
from smoking overnight before experimental sessions (Carter et al., 2009; Perkins et al., 1994, 
1996, 2017a, 2018; Rukstalis et al., 2005). In context of the current study, abstinence prior to 
sessions ensures minimal levels of blood nicotine in all participants and minimizes confounding 
effects of recent smoking—such as rapid satiation during self-administration testing—which might 
lead to avoidance of nicotine to prevent toxicity (Carter et al., 2009).  
1.3.1.1 Free choice 
In a free choice paradigm, participants choose unrestricted, or in ad lib fashion, between 
concurrently available doses of a drug. The number of doses presented within each session can be 
two (e.g., placebo vs. active, low vs. high, etc.) or greater (e.g., placebo vs. low vs. high). 
Participants may choose to abstain or consume as much drug as they would like, over a fixed 
period of time. Using fixed session durations prevents confounding between drug consumption 
and duration—if session durations were dependent on continued drug consumption, some 
participants may choose to abstain or consume minimal amounts of drug to leave sooner 
(MacKillop & Murphy, 2013).  
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The main dependent variable in the free choice paradigm is typically the difference in 
amount (if any) of each drug dose consumed, expressed in absolute number of choices or as a 
proportion. Variability in the total number of choices in a free choice procedure limits this 
paradigm from being used to identify differences in “reinforcement” because determining whether 
one dose was chosen significantly more than another depends on the total number of choices. If 
that is free to vary between participants, the number of choices for the active drug to be self-
administered significantly more than placebo would also vary (even if the proportion of choices 
were the same). For example, if one participant were to self-administer the active dose fourteen 
times and choose the placebo six times, their proportion of active choices (70%) would be the same 
for another participant who chose the active dose seven out of ten times (70%). The binomial 
probability of active drug choices for the first participant (p = 0.04), but not the second participant 
(p = 0.12), would be statistically significant (i.e., p < .05), indicating that the difference in number 
of choices was not due to chance for the first participant only. Using a procedure with a fixed 
number of total choices would allow for an a priori defined minimum number of choices for a dose 
to be self-administered reliably more than placebo, consistent across all participants. Lastly, an 
unrestricted amount of drug is typically provided to the participant for free—there is no financial 
or behavioral expenditure required to obtain it. Thus, it is possible that consumption may be 
inflated when using this procedure, relative to others described below.  
1.3.1.2 Operant response 
Operant self-administration procedures are the most commonly used to assess drug 
reinforcement, especially in animal models (Rupprecht et al., 2015). These studies require a 
behavioral response (e.g., lever press, mouse click, button press, etc.) for the participant to gain 
access to the drug (Higgins & Hughes, 1998). The interval between each presentation of the 
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reinforcer (i.e., earning a unit of drug) largely depends on the schedule of reinforcement. Studies 
using a fixed ratio (FR) schedule require a constant number of responses per unit of drug (Murphy 
& Lupfer, 2014). For example, a study using an FR10 schedule would require a participant click a 
mouse button ten times, any time they would like over the course of a session, to earn a puff from 
a cigarette (e.g., a unit of drug). Drug may also be available on a progressive ratio (PR) schedule, 
which requires a steadily increasing number of responses in order to earn each unit of drug 
(Murphy & Lupfer, 2014). For example, an initial cigarette puff may require 10 button presses and 
increase by 50% for each subsequent puff (i.e., “PR50”; 10, 15, 23, 34, 51…). As in the free choice 
paradigm, different doses can be tested across separate sessions to assess dose-effects on 
reinforcement. Concurrent schedules, which allow the participant to choose to work for one of two 
doses simultaneously, may also be used to assess relative reinforcement between doses more 
directly (Murphy & Lupfer, 2014; Perkins, Jacobs, Sanders, & Caggiula, 2002).  
1.3.1.3 Forced choice 
In the forced choice paradigm, participants are presented with a pair of doses (or products 
differing in other ways but identical in appearance) and are instructed to self-administer any 
combination of the two products according to their preference (Carter et al., 2009; de Wit & 
Johanson, 1987; Perkins et al., 1994, 1996, 2017a). The total number of choices within each 
session is typically fixed across all participants. For example, if instructed to take a total of four 
puffs from some combination of “Cigarette A” or “Cigarette B”, a participant could choose one 
puff from one and three from the other, two from each, or all four from just one of the cigarettes. 
Generally, the dependent variable is the number or percent of choices for one dose over another. 
One advantage of the forced choice paradigm is the fixed number of choices. As described above, 
using a fixed total number of choices allows for a clearly defined minimum difference needed for 
 12 
one dose to be self-administered to a greater degree than another. Another advantage is that the 
fixed number of choices is usually kept somewhat low, thus reducing the likelihood that a smoker 
will become satiated or suffer adverse effects from toxicity, which could lead to differential intake 
due to avoidance of further intake from one of the options. In the next section, I will discuss 
application of a choice procedure in recent research of reduced nicotine content cigarettes. 
1.4 Research on Acute Relative Reinforcing Effects of Nicotine via SPECTRUM Cigarettes 
Higgins et al. (2017) examined preference of SPECTRUM reduced nicotine cigarettes 
(RNC) in a relatively large sample of smokers considered “vulnerable” to tobacco addiction 
(N=169; three subgroups characterized by a current affective disorder diagnosis (n=56), history of 
opioid dependence (n=60), or low SES women (n=53)). All sessions followed overnight abstinence 
and participants took two puffs from their own brand of commercial cigarette upon arrival. In the 
first phase of the study, participants were instructed to freely smoke one of four SPECTRUM 
cigarettes (0.4, 2.4, 5.2, & 15.8 mg/g; one per session, cigarettes identified by letter code). In the 
next phase, participants were presented with all possible dose pairs (one pair per session) in six 3-
hr sessions. Using a hybrid of free choice and operant response methods, participants could choose 
to abstain or respond on an FR10 schedule to receive two puffs from one of the available cigarettes, 
up to as many puffs as they would like over the 3-hr session.  
Results indicated that when collapsing across all vulnerable population groups, participants 
chose the higher nicotine content cigarette significantly more than the lower nicotine content, in 
all dose pairs (Higgins et al., 2017). Choice across dose pairs did not vary due to dependence 
severity or number of smoking-related chronic health conditions (Higgins et al., 2018; Streck et 
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al., 2018). However, vulnerability groups differed when choosing between the 2.4 and 0.4 mg/g 
doses (Higgins et al., 2017). Those with an affective disorder diagnosis chose the 2.4 mg/g dose 
significantly more than the 0.4 mg/g, whereas there were no differences in choice between these 
doses for the opioid dependent and low SES women groups. Together, this suggests that certain 
subpopulations of smokers may have differential sensitivity to nicotine reinforcement, possibly 
related to having a diagnosed psychiatric disorder.  
Using a lab-based procedure involving acute exposure to cigarettes, the Higgins et al. 
(2017) study addressed an important question of dose-response effects for choice behavior in a 
narrow sample of smokers with specific characteristics that potentially made them especially 
vulnerable to tobacco use. As noted by Higgins et al. (2017), results were clearly different from 
Donny et al. (2015), which found a significant difference in daily self-administration between 
cigarettes containing 15.8 mg/g versus those containing 2.4 mg/g or below, not between all groups 
randomized to the different nicotine content cigarettes (as Higgins found). As outlined next, this 
difference between study results could have been due to the widely differing samples (i.e., healthy 
adult smokers versus vulnerable populations) or other methodological discrepancies (e.g., acute 
within-subjects comparisons between all nicotine content levels versus between-subjects 
comparisons among groups exposed to just one level over an extended period of time).  
Methodologically, the statistics used by Higgins et al. did not seem to be well suited for 
the data. The authors used repeated measures analysis of variance to compare differences in 
proportion of choices across all dose pairs. This analysis assumes a normally distributed dependent 
variable (Brase & Brase, 2015); no information was provided on the distribution of choices or the 
number of participants who chose to abstain in each session (and how abstainers’ data were 
handled). It is likely that count data, which are bounded by zero, would not be normally distributed 
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(Brase & Brase, 2015). (Higgins was contacted by email on Nov 12, 2018 to provide these data 
but provided no response.) Thus, count data would be most appropriately analyzed using a statistic 
specialized for Poisson, binomial, or negative binomial distributions (Zuur, Ieno, Walker, 
Saveliev, & Smith, 2009).  
In summary, results of the lab-based study of smokers considered “vulnerable” to tobacco 
addiction (Higgins et al. 2017) varied from results reported from a six-week randomized trial with 
medically and socially typical adult smokers (Donny et al. 2015). In Higgins’ lab-based study, 
reductions in nicotine content decreased relative reinforcement effects of smoking across all dose 
pairs; each of the higher nicotine content cigarettes was chosen more than any of the lower content 
cigarettes. In contrast, results from Donny’s randomized trial identified significant declines in self-
administration between cigarettes containing ≥ 5.2 mg/g versus those ≤ 2.4 mg/g. These 
differences were possibly due to methodological factors identified above, including the disparate 
populations tested.  
1.5 Sensory Perceptions of Acute RNC Cigarette Use and Nicotine Reinforcement 
Pleasurable “sensory” perceptions of acute drug use (e.g. ‘liking’, ‘satisfying’, ‘strong’, 
etc.) can be assessed by self-report in self-administration studies to complement behavioral 
measures of reinforcement but, by definition, do not measure reinforcement per se (Bozarth, 1987; 
de Wit & Johanson, 1987). Despite this, sensory perceptions provide important interoceptive 
information to the user which may affect subsequent self-administration behavior. For example, a 
drug dose with greater pleasurable sensory perceptions may be more likely to be consumed and at 
greater levels than doses with fewer such effects. While earlier studies have identified dose-
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response effects of pleasurable sensory perceptions of acute SPECTRUM RNC cigarette use 
(Cassidy et al., 2018; Faulkner et al., 2017; Hatsukami et al., 2012; Higgins et al., 2017), there is 
little research directly associating these sensory perceptions with subsequent smoking behavior. 
One study of healthy dependent adult smokers found that the magnitude of difference in 
positive sensory perceptions of smoking SPECTRUM cigarettes most widely varying in nicotine 
content (0.4 & 16-17 mg/g) predicted preference for the 16-17 mg/g dose in a forced-choice 
paradigm (Perkins, Karelitz, & Kunkle, 2018). The likelihood of choosing the 16-17 mg/g cigarette 
increased with greater increases in positive sensory perceptions of the 16-17 vs. 0.4 mg/g 
cigarettes. Another recent study of smokers from Higgins et al. (2017) also examined the 
relationship between choice behavior and positive subjective perceptions of acute use of 
SPECTRUM cigarettes (Bergeria et al., 2019). As described above, participants were presented 
with all possible dose options and were free to complete a simple operant task to receive two puffs 
from one cigarette or another over a three-hour period (Higgins et al., 2017). Researchers found 
that among vulnerable population subgroups of smokers, greater differences in sensory perceptions 
were associated with more choices of the higher nicotine content cigarette across all dose pairs. 
Together, these findings suggest that pleasurable sensory perceptions may be related to the relative 
reinforcing effect of nicotine, but research is limited to studies of smokers with psychiatric 
conditions and other vulnerabilities to tobacco addiction (Bergeria et al., 2019), or limited number 
of nicotine contents compared (Perkins, Karelitz, & Kunkle, 2018). It is possible that forced-choice 
responding in healthy adult smokers may be related to positive sensory perceptions of smoking 
RNC cigarettes across a range of nicotine contents, but this has not been directly tested.  
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1.6 Gaps in the Literature 
Nicotine reduction policy may ease tobacco smoking’s burden on public health by reducing 
smoke exposure through decreasing cigarette consumption or by making it easier for established 
smokers to quit (Apelberg et al., 2018; Benowitz & Henningfield, 1994, 2013, 2018). Randomized 
clinical trial research has determined that a reduction in nicotine content in cigarettes from current 
levels (i.e., ~15-17 mg/g) to ≤ 2.4 mg/g is necessary to reduce self-administration in healthy adults 
already dependent on nicotine (Donny et al., 2015). It is unclear whether shorter-term lab-based 
studies of relative reinforcement, which may promise a much more efficient and quick method of 
arriving at similar findings, would be a useful adjunct for such clinical trial research. Specifically, 
lab-based studies examining dose-response effects of relative reinforcement and subjective 
perceptions of acute RNC cigarette use will be shown to have relevant clinically predictive validity 
only by relating those findings to results from clinical trials on smoking reduction with RNC 
cigarettes. If a shorter-term within-subjects study is able to detect a similar dose-response pattern 
of preference, or choice, as that found for ad lib self-administration in Donny et al. (2015), this 
method may be used to inform design of future such clinical trials. It could do so, for examples, 
by piloting specific components of a study, or as a more cost-effective method (i.e., requiring fewer 
participants, less cost for research staffing) to gauge likely responses in subpopulations of smokers 
or to test dose-response effects in novel or investigational tobacco products.  
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1.7 The Current Study 
The main purpose of the current study was to validate the use of a within-subjects forced-
choice procedure to determine how much of a decline in nicotine content from levels typically 
found in commercial brand cigarettes would be needed to significantly reduce cigarette preference 
(i.e., self-administration). Successful validation of this procedure for this purpose would be 
expected to result in a dose-response pattern of relative reinforcement consistent with changes in 
self-administration due to nicotine content reported in a seminal clinical trial by Donny and 
colleagues (2015). At the end of the six-week trial, Donny et al. found significant differences in 
the number of cigarettes smoked per day between groups assigned to exclusively use one of six 
levels of cigarettes varying in nicotine content. Groups assigned to contents ≤2.4 mg/g smoked 
significantly fewer cigarettes per day than groups assigned to use the 5.2 mg/g cigarette or the 
“standard” content cigarette of 15.8 mg/g (Donny et al., 2015).  
As a first step toward establishing predictive validity of the present forced-choice 
paradigm, Aim 1 intended to examine the pattern of choices between a range of higher nicotine 
content (NIC) cigarettes versus the very lowest content cigarette available—0.4 mg/g (termed here 
“very low nicotine content” or VLNC). I hypothesized that the number of choices for doses ≤ 2.4 
mg/g would be significantly lower than that for contents ≥ 5 mg/g, consistent with the pattern of 
differences in self-administered cigarettes per day observed by Donny et al. (2015). 
A secondary purpose of this study was to relate a composite measure of pleasurable 
subjective sensory perceptions of acutely smoking RNC cigarettes (as assessed in some earlier 
RNC studies) to subsequent choice behavior (i.e. relative reinforcement). Clinical substance abuse 
research typically assumes that a drug is reinforcing because of the acute pleasurable subjective 
effects it elicits, but little prior research has directly associated these self-report and self-
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administration measures (Perkins, Karelitz, & Kunkle, 2018). Thus, Aim 2 sought to examine 
whether pleasurable sensory perceptions of acute NIC vs. VLNC cigarette use varies due to 
nicotine content conditions and whether such responses mediate the relationship between nicotine 
content and forced-choice behavior, consistent with that choice behavior reflecting positive 
reinforcement. Results of Aim 2 aimed to extend findings of earlier research on the dose-response 
effects of acute subjective perceptions of smoking RNC cigarettes to acute relative nicotine 
reinforcement. 
As noted earlier, the fixed number of choices is a strength of the forced choice paradigm. 
This allows for an a priori defined minimum number of choices needed for one option to be chosen 
significantly more than the other, based on binomial probability. As another test of differences in 
choice between doses, Aim 3 assessed changes in the likelihood of each dose being chosen 
significantly more than the VLNC (defined as ≥12 of 16 NIC choices) as a function of nicotine 
content. I hypothesized that the likelihood of doses ≤2.4 mg/g being chosen ≥12 out of 16 times 
would be significantly lower compared to a standard content cigarette—17.4 mg/g—further 
suggesting consistency of results from this acute choice test with significant changes in daily 
smoking between groups differing in cigarette nicotine contents groups reported by Donny et al. 
(2015). 
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2.0 Method 
2.1 Overview 
The current study used a within-subjects design to assess dose response effects on acute 
subjective perceptions of smoking RNC cigarettes and self-administration behavior in a sample of 
adult dependent smokers. Eligible participants completed six, 3-hour sessions: an introductory 
session and five experimental sessions (all following 12 hours of abstinence). All experimental 
sessions were identical, varying only in the nicotine content of the SPECTRUM cigarette (1.3, 2.3, 
5.5, 11.2, and 17.4 mg/g; “NIC” dose) being compared with the 0.4 mg/g. Cigarettes were 
identified by letter code specific to the session, with order of the higher nicotine content cigarettes 
counter-balanced across sessions. During the introductory session, participants provided informed 
consent, completed screening questionnaires, and were introduced to the study procedures (but 
using their own brand of cigarette vs. 0.4 mg/g very low nicotine content or “VLNC” dose). All 
smoking was done through a smoking topography device, with timing and duration of the puffs 
controlled (i.e., guided) by instructions presented via computer (Perkins & Karelitz, 2019). 
Each session began with participants providing an expired-air carbon monoxide sample to 
confirm abstinence, followed by completion of self-report measures of nicotine withdrawal 
symptoms and craving. Next, were four “exposure” (or “sampling”) trials during which 
participants took four puffs from each cigarette in a fixed order (VLNC, NIC, NIC, VLNC), one 
cigarette every 20 mins. Sensory perceptions of smoking were collected after each exposure trial 
so that responses were to 4 puffs from only one cigarette or the other. Unrelated to the choice 
procedure, participants also completed a simple computer task—Apple Picker—assessing 
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reinforcement enhancing effects of nicotine following exposure trials 2, 3, and 4. (This computer 
task was added to take advantage of the downtime between exposure trials to initially pilot nicotine 
dose response effects on enhancing reinforcement of non-drug related reinforcers. The Apple 
Picker task and its use in assessing reinforcement enhancing effects of nicotine have been 
described in detail elsewhere [Perkins, Karelitz, Boldry, 2017]; no additional procedures as part of 
this pilot testing occurred once the forced-choice trials began.) Last were four forced-choice 
trials—one every 10 mins—to assess acute relative reinforcement, during which participants were 
presented with both cigarettes and instructed to take four guided puffs from any combination of 
the cigarettes they would like. All procedures were reviewed and approved by the University of 
Pittsburgh Institutional Review Board (IRB #PRO13060083). 
2.2 Inclusion and Exclusion Criteria 
Eligible participants were those who have smoked >5 cigarettes per day for the past 12 
months, were not interested in quitting, and met DSM-V criteria for tobacco dependence 
(American Psychiatric Association, 2013). Exclusion criteria included current psychiatric 
diagnosis, intending to quit soon, current use of psychiatric or smoking cessation medications, 
current nicotine replacement therapy use, pregnancy, and currently nursing mothers. These criteria 
were chosen to obtain a sample that generally reflected the non-treatment seeking smokers in 
Donny et al. (2015). All participants were recruited from the Pittsburgh area using flyers and ads 
on Craigslist and Facebook 
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2.3 Procedure 
2.3.1  Telephone eligibility screen 
Potential participants initially responded to study advertisements via telephone or Qualtrics 
online pre-screening. All were then contacted via telephone by study staff and presented with a 
brief overview of the study followed by a 10-minute phone interview to determine eligibility. 
Those eligible were provided additional details about the study and scheduled for their introductory 
session.  
2.3.2  Introductory session 
Participants were instructed to abstain from all nicotine and tobacco products for 12 hours 
prior to this session and to bring an unopened pack of their preferred brand of cigarettes. An 
unopened pack was necessary to ensure there would be enough cigarettes to be used in the 
introductory session. Informed consent was obtained upon arrival, followed by confirmation of 
12-hr abstinence from combusted tobacco products via expired-air carbon monoxide (CO) sample 
≤10 ppm (Benowitz et al., 2019; SRNT Subcommittee on Biochemical Verification, 2002). Female 
participants provided a urine sample to test for pregnancy; none of the pregnancy tests were 
positive. All participants completed questionnaires of smoking and demographic information 
before learning and practicing study procedures (described in detail below). Cigarettes used in this 
session came from the unopened pack provided by the participant and the 0.4 mg/g “VLNC” dose 
provided by the researcher.  
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2.3.3  Experimental sessions 
A visual overview of the session procedures is presented in Figure 1. As in the introductory 
session, participants were instructed to abstain from nicotine and tobacco products for 12 hours 
before all experimental sessions to ensure minimal blood nicotine levels prior to testing in all 
participants, thus minimizing risk of nicotine satiation during the choice procedure trials. An 
expired-air CO sample was collected upon arrival, those with CO >10 ppm or reporting any 
smoking during the abstinence period were rescheduled. Next, participants completed baseline 
assessments of craving and withdrawal, as a manipulation check (see Preliminary Analyses 
subsection in Analysis Plan below).  
Once the baseline forms were completed, participants were told the letter codes 
corresponding to the 0.4 mg/g versus higher nicotine cigarettes specific to the day (“A” and “B” 
for session 1, “C” and D” for session 2, “E” and “F” for session 3, etc.). Specifically, participants 
were told “You will be given two different cigarettes, at least one of which will contain nicotine. 
They will be called cigarette ‘A’ and cigarette ‘B’”. Next, was the first of four exposure trials, one 
every 20 minutes. The exposure trials were necessary to allow participants to sample the cigarettes 
to inform choice later in the session. During each exposure trial, participants took four puffs from 
one of two SPECTRUM cigarettes through a smoking topography device, guided by instructions 
presented on a computer screen (described in greater detail below). Immediately after taking the 
puffs, participants completed a sensory rating form (see Appendix). Cigarettes were presented in 
a fixed order in these four exposure trials across all sessions (VLNC, NIC, NIC, VLNC) to provide 
adequate exposure to inform subsequent choice, while also minimizing carryover effects for initial 
sampling of each cigarette. Earlier research has shown that differences between cigarettes varying 
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in nicotine content are perceived to be greater when compared sequentially within a single session 
versus independently in separate testing sessions (Perkins et al., 2002).   
As briefly noted above, and unrelated to the choice procedure, participants engaged in an 
operant computer task during the downtime between exposure trials. The task, Apple Picker 
(described in more detail elsewhere; Perkins, Karelitz, & Boldry, 2017), involved simple 
responding on a keypad to obtain brief 30-sec clips of audio (music), video, or pictorial stimuli 
only for as long as desired, for up to a maximum of 15 mins. This pilot was aimed at assessing the 
reinforcement enhancement effects of nicotine via SPECTRUM cigarettes. This computer task 
occurred following exposure trials 2, 3, and 4; all choice procedures specific to the current study 
followed the final computer task.  
These exposure trials were followed by four forced choice trials, one every 10 minutes. In 
the forced choice trials, both cigarettes were presented concurrently. The researcher inserted each 
cigarette into separate smoking topography devices labeled with their respective letter code from 
the exposure trials. Participants were instructed to first light both cigarettes (without taking a puff) 
and then take four puffs from any combination of the cigarettes based on their preference (e.g., 2 
from each, 1 from one and 3 from other, or all 4 from one cigarette). As in the earlier trials, timing 
and duration of each puff was guided by instructions displayed on a computer screen and 
confirmed by CReSS-obtained smoking topography data. 
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Figure 1 Format of experimental sessions 
 
2.3.4  Research cigarettes 
SPECTRUM brand cigarettes (22nd Century Group http://www.xxiicentury.com) differing 
in nicotine content (see Table 1) were used. Menthol and non-menthol cigarettes were provided 
based on participant’s self-reported preference. Given the very slight difference in nicotine content 
between menthol and non-menthol cigarettes, the mean content between menthol and non-menthol 
cigarettes were used to describe each level. These specific nicotine contents were chosen to mostly 
to match those used in Donny et al. (2015). The 11.2 mg/g cigarette—which was not tested in 
Donny et al.—was included to anticipate a potential outcome where choice for all contents ≤5.5 
mg/g were significantly lower than the number of choices for the 17.4 mg/g. In this case, having 
an additional level between 5.5 and 17.4 mg/g would narrow the nicotine content gap and may 
identify a threshold where choice was significantly greater than lower contents but similar to that 
of a standard content cigarette—17.4 mg/g. 
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Table 1 Nicotine, menthol, and tar information for SPECTRUM cigarettes by nicotine and menthol status 
Menthol Non-menthol 
Dose Label 
Nicotine 
Content (mg/g) 
Menthol 
Content (mg/g) 
Tar Yield 
(mg/cig) 
Nicotine 
Content (mg/g) 
Menthol 
Content (mg/g) 
Tar Yield 
(mg/cig) 
VLNC 0.39 1.08 8.1 0.44 — 8.4 
1.3 mg/g 1.24 2.08 8.5 1.29 — 8.1 
2.3 mg/g 2.26 1.89 8.9 2.27 — 9.1 
5.5 mg/g 5.65 1.46 8.3 5.33 — 8.6 
11.2 mg/g 11.67 0.91 9.8 10.81 — 13.5 
17.4 mg/g 16.14 1.51 10.6 18.66 — 10.1 
Note. Dose labels are the mean nicotine content between menthol and non-menthol cigarettes; 
mg/g is milligram per gram of tobacco; mg/cig is milligram per cigarette; VLNC is very low 
nicotine content. All values provided by RTI International. 
The lowest available dose, 0.4 mg/g, was presented concurrently with each of the higher 
doses during forced-choice trials across sessions. Although a true “placebo” tobacco cigarette 
would be ideal, SPECTRUM is not available in a 0 mg/g nicotine version, likely because 
mandating nicotine-free cigarettes is prohibited by the Family Smoking Prevention and Tobacco 
Control Act (FSPTCA). Comparing against the lowest available dose was necessary to conduct a 
choice procedure, so that only the nicotine content varied between the two cigarettes being 
compared. 
Comparisons among each permutation of nicotine content pairs (as in Higgins et al., 2017) 
was not used in the current study for a few reasons. First, it would have increased the number of 
sessions from six to sixteen, increasing the burden of participation and making it harder to recruit 
and retain participants. It is also possible that concurrent within-session smoking of the higher 
nicotine levels participants could cause some participants to become satiated, leading to actively 
avoiding puffs from the higher nicotine content cigarette in later choice trials. Lastly, comparing 
each content against the same 0.4 mg/g alternative allows for a much clearer interpretation of 
results, as the point of comparison is fixed across each of the nicotine conditions.  
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2.3.5  Control of smoke exposure 
All puffing was guided by instructions presented to the participant on a computer monitor. 
As shown in Figure 2, participants were instructed to “Get Ready” (2 sec) and then “Put the 
Mouthpiece to your lips” (2 sec), then “Inhale” (2 sec), “Breathe in and hold” (2 sec), and “Exhale” 
(2 sec), followed by “In a moment you’ll do that again. Wait for instructions” (20 sec). The 
instructions ended following the last puff of each trial. Smoking using this procedure has been 
shown to result in consistent exposure (i.e., puff volume) within and between cigarettes varying in 
nicotine content (Perkins & Karelitz, 2019). 
 
 
Figure 2 Instructions presented to participants on the timing of each step in taking one puff, displayed on a 
computer monitor. (From Perkins & Karelitz, 2019) 
 
 
2 Seconds 
2 Seconds 
2 Seconds 
2 Seconds  
 
2 Seconds 
20 Seconds  
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2.4 Primary Measures  
2.4.1  Positive sensory perceptions of smoking 
Acute positive sensory perceptions of each acute cigarette smoking exposure were 
measured immediately after the last puff taken in the four exposure trials, with self-report items 
on a 0-100 visual analog scale (Appendix). Items of interest asked how much “liking”, 
“satisfaction”, “nicotine”, and “flavor” was experienced, and how “strong” the cigarette was. 
These measures have been found to be sensitive to differences in nicotine content (Faulkner et al., 
2017; Perkins et al., 2002, 2006, 2018). A composite positive sensory response—the Acute 
Cigarette Perception (ACP) measure—was calculated as the mean of the “liking”, “satisfaction”, 
“nicotine”, “flavor”, and “strong” items. Earlier research using this composite measure found that 
it was positively associated with choice for 17 mg/g, when presented concurrently with a 0.4 mg/g 
alternative (Perkins et al., 2018). Difference scores (NIC – VLNC) were calculated for each 
sensory response item by nicotine content to separate effects of nicotine from smoking behavior. 
The difference in sensory perceptions between NIC and VLNC were used in analyses described in 
detail below. (Additional items collected on this form, including measures of “smooth”, “harsh” 
and “similar to your own brand”, are not part of the ACP and were not included in analyses of 
positive sensory perceptions of smoking which were focused on sensory perceptions items relating 
to positive reinforcement.) 
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2.4.2  Self-administration during forced choice procedure 
The number of puffs taken from each cigarette (VLNC & NIC) during the subsequent four 
forced choice trials was measured using smoking topography devices. Study staff inserted each 
cigarette into its own portable Clinical Research Support System (CReSS; Borgwaldt KC, Inc., 
Richmond VA), which recorded the number of puffs taken from each cigarette (as well as other 
smoking topography measures described in greater detail below). The absolute number of puffs 
for the higher nicotine content cigarette (NIC) used in analyses. 
2.5 Secondary Measures  
2.5.1  Craving 
Craving for cigarettes was assessed upon arrival using the 4-item Questionnaire of 
Smoking Urges (QSU-4; Carter & Tiffany, 2001). Participants responded using a 0-100 visual 
analog scale, consistent with other studies using this measure (Conklin et al., 2015, 2018, Perkins, 
Karelitz, & Michael, 2017, Sayette et al., 2000). A composite craving score was computed by 
taking the mean of all four items. The QSU-4 has been shown to have high levels of internal 
consistency, with Cronbach’s alpha values ranging .82 to .94 (Litvin, Kovacs, Hayes, & Brandon, 
2012).  
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2.5.2  Withdrawal 
Severity of nicotine withdrawal symptoms were measured upon arrival using the 
Minnesota Nicotine Withdrawal Scale (MNWS; Hughes & Hatsukami, 1986). The MNWS is an 
eight-item self-report scale, measured on a 0-100 visual analog scale. A single withdrawal score 
was calculated as the mean of all eight items. This measure has been found to have high internal 
consistency (Cronbach’s alpha >0.85), stability in measurement over time (test-retest correlation 
of 0.71), and high construct validity (Etter & Hughes, 2006).  
2.5.3  Smoking topography 
All cigarettes were smoked through a portable CReSS smoking topography device. This 
device collects several measures of smoking topography for each puff (e.g., volume, duration, 
interpuff interval, etc.), which was converted to composite or mean values consistent with prior 
research to allow comparisons between cigarettes (Conklin et al., 2015, 2018; Perkins et al., 2011, 
2012, 2019; Shiffman, 2018a, 2018b; Strasser et al., 2004). Topography measures included total 
puff volume (ml), total number of puffs, and mean puff volume (ml). These variables were 
collected to confirm consistency in smoking exposure across SPECTRUM cigarettes varying in 
nicotine content and to record the number of VLNC and NIC puffs during forced-choice 
procedures. 
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2.6 Analysis Plan 
2.6.1  Preliminary analyses 
All analyses were performed using SPSS 25.0 (IBM, Chicago, IL), with alpha set to 0.05. 
Baseline craving and withdrawal scores were compared across nicotine conditions using separate 
linear mixed models (LMM), with a random intercept and fixed effects for the intercept and 
nicotine condition. These analyses confirmed consistent within-subjects levels of overnight 
abstinence induced craving and withdrawal symptoms upon arrival to each session. Difference in 
exposure trial puff volumes (NIC – VLNC) across nicotine content conditions were compared 
using LMMs to confirm consistent smoke exposure.  
2.6.2  Aim 1 analyses: Choice data 
Generalized linear mixed models (SPSS GENLINMIXED command) using a Poisson 
probability distribution and log link were used in all analyses of choice data. Assuming a Poisson 
distribution makes this analysis appropriate for use with count data, which consists of non-
negative, discrete integers (Garson, 2020). Generalized linear mixed models (GLMM) are 
preferred over general linear models (e.g., repeated measures analysis of variance) when the 
dependent variable is not normally distributed (Brase & Brase, 2015; Garson, 2020). As noted 
earlier, count data is often not normally distributed and—when not zero-inflated—should be 
analyzed using a statistic specialized for a Poisson distribution (current data were not zero-
inflated—only 3 out of 181 choices [1.7%] were zeroes; Zuur, Ieno, Walker, Saveliev, & Smith, 
2009). Further, GLMMs, unlike general linear models, do not require consistent number of 
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measurements across groups and is able to account for variance occurring at lower- and higher-
levels of observation. GLMM analysis is typically used to examine data arranged in a hierarchical 
structure (Ciarleglio & Makuch, 2007; Raudenbush & Bryk, 2002; Singer & Willett, 2003). 
Hierarchical data consists of lower-level observations nested within higher-level groups (the 
higher-level groups can also be nested within even higher-level groups and so on). For the current 
study, lower-level within-session forced-choice trials were nested within higher-level nicotine 
content conditions.  
Initial GLMM analysis examined influences on the difference in choice at the lower-level 
(i.e., between trials), upper-level (i.e., between nicotine contents), and cross-level interaction 
where patterns of choosing across forced-choice trials may vary as a function of nicotine content 
(Mathieu, Aguinis, Culpepper, & Chen, 2012). This analysis determined whether the number of 
NIC puff choices varied systematically across within-session trials and as a function of the nicotine 
content condition. Specifically, this analysis was run to rule out the possibility that participants 
avoided the higher nicotine content cigarette due to satiation over the course of the four choice 
trials, which may have occurred at higher (but not lower) nicotine content conditions. This model 
included a random intercept and fixed effects for the intercept, nicotine condition, and trial. 
Discussed further in the Results section, there were no significant effects for the main effect of 
trial or for the trial by nicotine condition interaction, so choice data were collapsed and summed 
across trials for all further analyses.  
For the primary analysis, GLMMs were used to assess change in the number of NIC puff 
choices across nicotine content conditions. This model included a random intercept and fixed 
effects for the intercept and nicotine condition. Several post-hoc exploratory models were also 
estimated. Exploratory factors included number of cigarettes smoked per day, sex, menthol 
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preference, and ethnicity (Caucasian vs. African American/Black). These factors were specifically 
chosen as they have been previously identified as research priorities for studies assessing 
behavioral and sensory responses to using reduced nicotine content cigarettes (Hatsukami, 
Benowitz, Donny, Henningfield, & Zeller, 2013). Cigarettes per day was included as a continuous 
time-invariant covariate; additional models separately assessed moderating effects of sex, menthol 
preference, ethnicity (African American/Black or Caucasian), and their respective interaction with 
nicotine content condition. Significant interactions with nicotine condition were decomposed with 
post-hoc tests, where models were run separately for each level of the categorical moderator. 
2.6.3  Aim 2 analyses: Sensory data 
Analyses relating to Aim 2 focused on the relationship between positive sensory 
perceptions of acute RNC cigarette use and subsequent choice behavior. First, separate LMM 
analyses were used to assess dose-response effects for the self-reported acute positive sensory 
perceptions: composite ACP, ‘Liking’, ‘Satisfying’, ‘How Much Nicotine’, ‘Strong’, and ‘Flavor’. 
Difference scores (NIC – VLNC) of cigarette ratings obtained during the exposure trials were 
compared across the five levels of nicotine content. Menthol preference was also explored in post-
hoc analyses as a potential moderator of nicotine content effects on sensory perceptions by 
inclusion of menthol as a between-subjects factor and the interaction of menthol by nicotine 
content condition.  
The next set of analyses were intended to extend earlier findings by using linear mixed 
effects mediation analysis to determine whether the magnitude of difference in the ACP composite 
measure mediated the relationship between forced choice responding and nicotine content 
conditions. Mediation occurs when the independent variable’s (X) effect on the dependent variable 
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(Y) occurs through the independent variable’s effect on the mediator variable (M) (Hayes, 2015; 
Hayes & Rockwood, 2019). The mediator can be considered the mechanism through which the 
independent variable is able to affect the dependent variable (Hayes, 2015; Hayes & Rockwood, 
2019). This process is visualized using examples from the current study in Figure 3 below; path 
‘a’ is the effect of nicotine content condition on the ACP, path ‘b’ is the effect of ACP on the 
number of NIC choices, and path ‘c´’ is the direct effect of nicotine content condition on the 
number of NIC choices. The product ‘ab’ is termed the “indirect effect”, which is the effect of 
nicotine content condition on choice through the ACP (i.e., the product of coefficients method; 
MacKinnon et al., 2002). The linear mixed effects mediation analysis was performed using the 
MLmed SPSS macro (Hayes, 2015; Hayes & Rockwood, 2019; Rockwood, 2017; downloaded 
from https://njrockwood.com/mlmed), using a random intercept, random slopes for the nicotine 
condition variable, and a diagonal covariance matrix. All mediation effects were estimated using 
a restricted maximum likelihood (REML) estimator and 10,000 Monte Carlo samples to obtain 
95% confidence intervals for the estimates. 
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Figure 3 Conceptual model of the mediation analysis. Path ‘a’ is the effect of nicotine content condition on 
ACP; Path ‘b’ is the effect of ACP on forced choice; Path ‘c´’ is the direct effect of nicotine content condition 
on forced choice. 
 
An additional moderated mediation model was run using MLmed, assessing the 
moderating effect of menthol preference on path ‘a’ (now path ‘a1’; visualized in Figure 4). This 
model built upon the previous by testing whether the mediation process described above varied as 
a function of menthol preference (W). Here, the moderator acts to set the context under which 
mediation occurs through path ‘a2’. The index of mediated moderation is the product of the effect 
of the interaction between the independent (X) and moderator (W) variables (X*W, path a3 not 
shown in Figure 4) on the mediator (M) and path b (the effect of the mediator on the dependent 
variable): a3*b (Hayes, 2015; Hayes & Rockwood, 2019). To put this in clearer terms, an example 
of moderated mediation in context of the current study would be a mediation effect of ACP on the 
relationship between nicotine content condition and choice being present for non-menthol but not 
menthol smokers. 
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Figure 4 Conceptual model of the moderated mediation analysis.Path ‘a1’ is the effect of nicotine content 
condition on ACP; Path ‘a2’ is the moderating effect of menthol on the relationship between nicotine content 
condition and ACP; Path ‘b’ is the effect of ACP on forced choice; Path ‘c´’ is the direct effect of nicotine 
content condition on forced choice. 
 
2.6.4  Aim 3 analyses 
Aim 3 analyses assessed dose-response effects on the likelihood of individual participants 
self-administering the NIC dose significantly greater than the VLNC. For a NIC dose to be self-
administered significantly more than the VLNC dose, it must have been chosen ≥12 out of the 16 
total forced choice puffs. This threshold was determined a priori using the formula for binomial 
probability (Brase & Brase, 2015): 
𝑏𝑏(𝑥𝑥;𝑛𝑛,𝑃𝑃) = � 𝑛𝑛![𝑥𝑥! (𝑛𝑛 − 𝑥𝑥)!]� ∗  𝑃𝑃𝑥𝑥 ∗ (1 − 𝑃𝑃)𝑛𝑛−𝑥𝑥 
In this formula, n is the total number of choice opportunities, x is the number of NIC dose 
choices, P is the probability of choosing the NIC dose for an individual choice opportunity, and b 
is the binomial probability (Brase & Brase, 2015). In the present study, there were 16 total choice 
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opportunities (n) with a 0.50 probability of choosing either dose (NIC or VLNC; P), resulting in 
the formula: 
𝑏𝑏(𝑥𝑥; 16, 0.50) = � 16![𝑥𝑥! (16 − 𝑥𝑥)!]� ∗  0.50𝑥𝑥 ∗ (1 − 0.50)16−𝑥𝑥 
Thus, ≥12 NIC choices (x) would result in binomial probability (b) less than 0.05: 
𝑏𝑏(12; 16, 0.50) = � 16![12! (16 − 12)!]� ∗  0.5012 ∗ (1 − 0.50)16−12 
𝑏𝑏(12; 16, 0.50) = 0.028 
The absolute number of choices for the NIC cigarette was converted into a binary variable, 
with ‘1’ indicating ≥12 NIC choices and ‘0’ for <12 NIC choices. A GLMM analysis tested for a 
dose-response effect for the likelihood of meeting the ≥12 criterion. The GLMM analysis assumed 
a binary logistic distribution for the dichotomous criterion variable and used a logit link. The 17.4 
mg/g content served as the reference group to further confirm consistency in results with Donny 
et al. (2015). 
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3.0 Results 
3.1 Participants 
A total of sixty people attended the introductory session and provided informed consent; 
fourteen did not meet inclusion criteria (1 smoked <5 cigs/day, 2 were not DSM-V dependent, 11 
had CO > 10 ppm) and were excluded. Nine other participants who did meet inclusion criteria did 
not show up for any additional sessions beyond the introductory session, resulting in a final sample 
of 37 (20 male, 17 female). Of the 37 participants, two had incomplete data due to moving out of 
the area before being able to complete all sessions—one participant was missing data for one 
session (5.5 mg/g condition) and the other is missing data for three sessions (5.5, 11.2, and 17.4 
mg/g conditions). All available data were used in the analyses, resulting in final sample sizes per 
nicotine condition: 37 for 1.3 mg/g, 37 for 2.3 mg/g, 35 for 5.5 mg/g, 36 for 11.2 mg/g, and 36 for 
the 17.4 mg/g condition.  
Sample demographics by menthol preference are presented in Table 2. Overall, the mean 
(SD) age was 37.1 (11.5) years; they smoked an average of 13.2 (4.8) cigarettes per day, smoking 
at their current rate for 11.0 (10.1) years, with a mean nicotine content of their reported usual brand 
of 17.9 (1.9) mg/g (Carmines & Gillman, 2019). There were almost equal numbers of smokers 
who preferred non-menthol (n=17, 45.9%) and menthol (n=20, 54.1%) cigarettes. The sample as 
a whole was moderately nicotine dependent, with a mean Fagerström Test of Nicotine Dependence 
(FTND) score of 4.4 (2.0). Sample characteristics did not vary between sexes, but menthol 
preferring smokers were more likely to be African American or Black (n = 14) than Caucasian 
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(n=4), χ2(1) = 16.89, p = 0.00004 (two additional menthol smokers were Hispanic and more than 
one ethnicity). 
 
Table 2 Participant demographics by menthol preference 
 
Menthol 
(n=20) 
Non-menthol 
(n=17) 
Overall 
(n=37) 
Age 37.9 (±11.0) 36.1 (±12.4) 37.1 (±11.5) 
Sex    
Male 9 11 20 
Female 11 6 17 
Ethnicity    
Caucasian 4 14 18 
African American/Black 14 1 15 
Hispanic 1 0 1 
More than one 1 2 3 
Cigarettes per day 12.0 (±4.7) 14.7 (±4.6) 13.2 (±4.8) 
Own brand nicotine content 
(mg/g) 
18.1 (±1.3) 17.7 (±2.5) 17.9 (±1.9) 
Own brand menthol content 
(mg/cig) 
5.1 (±0.4) — — 
FTND 4.8 (±2.0) 3.9 (±2.1) 4.4 (±2.0) 
Note. Values are means (±standard deviation) or frequencies; mg/g is 
milligram of nicotine per gram of tobacco; mg/cig is milligram of menthol 
per cigarette. 
 
3.2 Preliminary Analyses 
Means and standard errors for baseline assessed expired-air CO, MNWS withdrawal, and 
QSU-4 craving are presented in Table 3. As expected, there were no significant differences across 
sessions for any of these measures (F’s ≤ 1.40, p’s ≥ 0.26). Similarly, there was no main effect of 
nicotine content condition on the difference (NIC – VLNC) in exposure trial puff volume, F(4,172) 
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= 0.45, p = 0.77. Together, these results show consistent overnight abstinence induced effects and 
sampling trial smoke exposure across all nicotine content conditions. 
 
Table 3 Means, standard errors, and F-values for baseline measures 
 Nicotine Content Condition   
 1.3 mg/g 2.3 mg/g 5.5 mg/g 11.2 mg/g 17.4 mg/g  
Variable M SE M SE M SE M SE M SE F p 
Expired-air CO (ppm) 5.60 0.41 5.57 0.41 5.26 0.41 5.84 0.41 5.29 0.41 0.86 0.49 
MNWS withdrawal 27.72 3.23 29.09 3.23 31.89 3.26 28.82 3.25 26.56 3.25 1.33 0.26 
QSU-4 craving 74.08 3.92 74.18 3.92 74.26 3.97 74.78 3.95 73.71 3.95 0.03 0.99 
Note: F is for effect of nicotine content condition; degrees of freedom of (4, 176) for all F’s; 
MNWS and QSU measured on 0-100 VAS. 
 
3.3 Aim 1 Analyses 
3.3.1  Initial test of trial-level effects on choice 
There was a significant main effect of nicotine condition, F(4, 704) = 2.62, p = 0.03, 
indicating that the number of NIC puff choices differed by nicotine condition when averaged 
across trials. The main effect of trial and the interaction of trial by nicotine condition were not 
significant—F(3, 704) = 0.64, p = 0.59 and F(12, 704) = 0.22, p = 0.99, respectively. In sum, 
choice varied due to nicotine condition but not across trials. These results indicate stability of 
responding within condition, supporting the notion that participants were not avoiding the higher 
nicotine content cigarette due to satiation as the choice trials progressed.  
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3.3.2  Main effect of nicotine condition on choice 
As mentioned above, all further analyses of choice responding used the session-level 
summed number of NIC choices (out of 16 total) for each condition. There was a significant main 
effect of nicotine content condition on the number of NIC puff choices, F(4, 176) = 2.62, p = 0.04. 
As illustrated in Figure 5, NIC choices increased with greater nicotine content. Also shown in 
Figure 5, the number of NIC choices was significantly greater than eight (i.e., none of the 95% 
CI’s overlapped with eight) across all nicotine conditions. As there were 16 total puffs per session, 
choosing the NIC cigarette eight or fewer times would have meant an equal or greater number of 
puffs for the VLNC cigarette (0.4 mg/g). Thus, each of the higher nicotine content cigarettes was 
chosen significantly more than the VLNC cigarette (i.e., significantly greater than eight). Pairwise 
comparisons indicated that the number of NIC choices for the 17.4 mg/g group was significantly 
greater than that for both the 2.3 and 1.3 mg/g groups, as hypothesized. The number of NIC choices 
for 2.3 mg/g was marginally lower than that of the 5.5 condition and significantly lower than the 
11.2 mg/g condition.  
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Figure 5 Mean number of NIC puff choices by nicotine content condition. Vertical bars represent 95% 
confidence intervals. Horizontal bars indicate significant pairwise differences between nicotine content 
conditions. Horizontal dashed line at 8 indicates no difference in choice from VLNC.  **p<.01, *p<.05, †p<.10. 
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3.3.3  Exploratory post-hoc analyses 
Separate exploratory post-hoc analyses were run to assess whether choice behavior across 
nicotine content conditions varied due to the number of cigarettes smoked per day, sex, menthol 
preference, and ethnicity (African American/Black and Caucasian only). Each factor (and the 
interaction with nicotine content condition for the dichotomous measures) was added to the 
generalized linear mixed model as fixed-effects.  
When controlling for cigarettes smoked per day, the main effect of nicotine content 
condition was still significant, F(4, 175) = 2.61, p = 0.04, but the main effect of cigarettes per day 
was not, F(1, 175) = 0.16, p = 0.69. Therefore, the effect of nicotine content condition on the 
number of NIC choices was consistent across all levels of cigarettes smoked per day.  
In the model adding factors of sex and the sex by nicotine condition interaction, the main 
effect of nicotine content condition was unchanged, F(4, 171) = 2.66, p = 0.04. Men (n=20) and 
women (n=17) did not differ in the magnitude of difference in choice overall (no main effect of 
sex, F(1, 171) = 2.90, p = 0.09) nor as a function of nicotine content condition (no interaction of 
sex by nicotine content, F(4, 171) = 1.33, p = 0.26).  
Regarding the moderating effects of menthol preference, there was a significant main effect 
of nicotine content condition, F(4, 171) = 3.08, p = 0.02, but a non-significant main effect of 
menthol, F(1, 171) = 0.15, p = 0.70. The lack of a significant main effect for menthol indicated 
similar magnitudes of difference in choice among menthol and non-menthol smokers when 
collapsing across all nicotine content conditions. More importantly, the interaction between 
menthol preference and nicotine content condition was significant—F(4, 171) = 3.64, p = 0.007—
providing evidence that menthol preference moderated the relationship between nicotine condition 
and puff choice. In other words, the pattern of difference in puff choice across nicotine conditions 
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differed between menthol and non-menthol smokers. To better understand how choice varied 
across nicotine conditions, follow up analyses examined the effect of nicotine condition on puff 
choice separately for menthol and non-menthol smokers.  
For non-menthol smokers (n=17), there was a significant main effect of nicotine content 
condition, F(4, 77) = 5.14, p = 0.001. Inspection of Figure 6 reveals an orderly dose effect in the 
number of NIC puff choices. The number of NIC choices for the 1.3 and 2.3 mg/g conditions were 
significantly lower than that for each of the higher nicotine content conditions, except for 2.3 vs. 
5.5 mg/g; there were no significant differences among the three highest nicotine content 
conditions. NIC choices at the two lowest contents were not significantly greater than that of the 
VLNC, as the respective 95% confidence intervals in Figure 6 each overlap with eight. 
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Figure 6 Mean number of NIC choices by nicotine content condition for non-menthol smokers. Vertical bars 
represent 95% confidence intervals. Horizontal bars indicate significant pairwise differences between 
nicotine content conditions. Horizontal dashed line at 8 indicates no difference in choice from VLNC. 
***p<.001, *p<.05. 
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For menthol smokers (n=20), in sharp contrast, the main effect of nicotine content 
condition was not significant, F(4, 94) = 1.06, p = 0.38. As shown in Figure 7, there was a zig-zag 
pattern in the number of NIC choices across nicotine content conditions, with no significant 
differences between any conditions. The number of NIC choices was significantly greater than 
choices for the VLNC cigarette for 1.3, 5.5, and 17.4 mg/g, but not the intermediate contents of 
2.3 or 11.2 mg/g.  
 
 
Figure 7 Mean number of NIC choices by nicotine content condition for menthol smokers. Vertical bars 
represent 95% confidence intervals. Horizontal dashed line at 8 indicates no difference in choice from VLNC. 
 
In the model testing the moderating effects of ethnicity (African American/Black [n=15] 
vs. Caucasian [n=18]), main effects of nicotine condition and ethnicity were not significant—F(4, 
151) = 1.64, p = 0.17 and F(1, 151) = 0.24, p = 0.63, respectively. However, there was a significant 
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interaction of nicotine condition by ethnicity, F(4, 151) = 2.66, p = 0.04. Means and 95% 
confidence intervals for NIC choices by nicotine condition and ethnic group are displayed in 
Figure 8. Analysis of each ethnicity separately revealed a significant main effect of nicotine 
condition for Caucasians (F(4, 81) = 4.14, p = 0.003), but not for African American/Black smokers 
(F(4, 70) = 0.20, p = 0.94). 
 
 
Figure 8 Mean number of NIC choices by nicotine content and ethnicity. Vertical bars represent 95% 
confidence intervals. Horizontal dashed line at 8 indicates no difference in choice from VLNC. 
 
Two additional post-hoc exploratory analyses were run in an attempt to distinguish 
between effects due to menthol preference and ethnicity. The first model explored the moderating 
effect of menthol preference in Caucasian participants. A similar analysis among African 
 47 
American/Black participants was not possible, as 14 out of 15 were menthol smokers (4 out of 18 
Caucasians smoked menthol cigarettes), but the moderating effect of ethnicity was able to be 
explored among menthol smokers. In the model assessing the moderating effect of menthol in 
Caucasian smokers, there was a significant main effect of nicotine condition—F(4, 76) = 3.00, p 
= 0.02—but the main effect of menthol and the interaction of menthol by nicotine condition were 
not significant—F(1, 76) = 0.06, p = 0.81 and F(4, 76) = 1.38, p = 0.25, respectively. Inspection 
of the mean number of NIC choices by menthol preference for Caucasian smokers displayed in 
Figure 9, shows a dose response increase in NIC Choices among non-menthol smokers (n=14) but 
a zig-zag pattern across nicotine contents for menthol smokers (n=4).  
 
 
Figure 9 Mean number of NIC choices by nicotine content and menthol for Caucasian smokers. Vertical bars 
represent 95% confidence intervals. Horizontal dashed line at 8 indicates no difference in choice from VLNC. 
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In the exploratory model assessing the moderating effect of ethnicity (African 
American/Black [n=14] vs. Caucasian [n=4]) in menthol smokers, neither the main effect of 
nicotine condition nor ethnicity were significant—F(4, 79) = 1.32, p = 0.27 and F(1, 79) = 0.29, p 
= 0.60, respectively. The interaction between nicotine condition and ethnicity was also not 
significant, F(4, 79) = 1.27, p = 0.29. Means and 95% confidence intervals for NIC choices by 
ethnic group for menthol smokers are displayed in Figure 10.  
 
 
Figure 10 Mean number of NIC choices by nicotine content and ethnicity for menthol smokers. Vertical bars 
represent 95% confidence intervals. Horizontal dashed line at 8 indicates no difference in choice from VLNC. 
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Although individual cell sizes were small, this series of analyses suggest that choice across 
nicotine contents varied among Caucasian smokers due to menthol preference but not between 
ethnicities in menthol smokers. Overall, it is not clear whether differences in choice were due to 
ethnicity or menthol preference.  
3.4 Aim 2 Analyses 
3.4.1  Main effect of nicotine condition on sensory perceptions 
Analysis of the composite ACP difference score (NIC – VLNC) revealed a significant main 
effect of nicotine condition, F(4, 141) = 6.61, p = 0.00007. Estimated mean ACP difference scores 
(with 95% CIs) by nicotine condition are illustrated in Figure 11. Other than the 1.3 mg/g 
condition, all nicotine contents were rated significantly more pleasurable than the concurrently 
presented VLNC, as denoted by 95% CIs not overlapping with zero. Significant between-condition 
differences are indicated by asterisks and brackets in Figure 11. Notably, the magnitude of 
difference was greater for: 17.4 mg/g vs. contents ≤ 5.5 mg/g; 11.2 mg/g vs. contents ≤ 2.3 mg/g; 
and 5.5 mg/g vs 1.3 m/g. This pattern of differences was consistent across almost all of the 
individual items comprising the composite ACP—‘Liking’, ‘Satisfying’, ‘How Much Nicotine’, 
and ‘Strong’. The main effect of nicotine content was marginal for ‘Flavor’. Estimated means, 
standard errors, and F-values for each of the sensory perceptions are presented in Table 4. 
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Figure 11 Mean difference (NIC-VLNC) in ACP composite score by nicotine content condition. Vertical bars 
represent 95% confidence intervals. Horizontal bars indicate significant pairwise differences between 
nicotine content conditions. ***p<.001, **p<.01, *p<.05. 
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Table 4 Means and standard errors for sensory response difference scores (NIC – VLNC) by nicotine 
condition 
 Nicotine Content Condition   
 1.3 mg/g 2.3 mg/g 5.5 mg/g 11.2 mg/g 17.4 mg/g  
Variable M SE M SE M SE M SE M SE F p 
Liking 6.82 3.56 7.66 3.56 16.24 3.65 16.40 3.61 26.97 3.61 6.16 < 0.001 
Satisfying 5.22 3.59 6.08 3.59 17.42 3.68 18.30 3.64 25.30 3.64 6.45 < 0.001 
How Much Nicotine 7.66 3.46 6.73 3.46 12.86 3.54 18.62 3.50 19.69 3.50 3.76 0.006 
Strong 0.45 3.77 3.76 3.77 12.51 3.85 19.55 3.81 21.12 3.81 9.06 < 0.001 
Flavor 4.00 3.71 6.78 3.71 8.02 3.80 12.89 3.76 15.93 3.76 2.20 0.07 
Note. M is mean; SE is standard error; F(4, 141) is for main effect of nicotine content condition. 
 
3.4.2  Exploratory moderation analyses 
Given the significant moderating effects of menthol and ethnicity on the relationship 
between nicotine content condition and choice behavior, menthol preference and ethnicity were 
also examined as a potential moderators of acute sensory perceptions across nicotine contents. This 
series of post hoc analyses explored whether any differences in sensory perceptions existed among 
levels of each factor (i.e., a main effect of menthol preference or ethnicity) and whether such 
differences varied as a function of nicotine content condition (i.e., an interaction with nicotine 
content). The ACP composite variable was examined first; any significant effects involving 
menthol or ethnicity were followed up by examining the five individual sensory perception items. 
Results of the menthol analyses by measure and effect are presented in Table 5. There was 
a significant interaction of menthol and nicotine condition for the ACP composite score. Among 
the individual sensory measures, there were significant effects (aside from significant main effects 
of nicotine content condition) for ‘Strong’, ‘Flavor’, and ‘How much nicotine’.  
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Table 5 Results of sensory perception analyses by nicotine condition, menthol, and nicotine condition by 
menthol 
 Effect 
 Nicotine Content Condition Menthol Nic Content X Menthol 
Variable F DF p F DF p F DF p 
ACP Composite 7.51 4, 137 < 0.001 0.72 1, 35 0.40 2.66 4, 137 0.04 
Liking 6.29 4, 137 < 0.001 0.0001 1, 35 0.99 1.07 4, 137 0.38 
Satisfying 6.76 4, 137 < 0.001 0.07 1, 35 0.79 1.60 4, 137 0.18 
How Much Nicotine 4.49 4, 137 0.002 0.25 1, 35 0.62 2.66 4, 137 0.04 
Strong 9.95 4, 137 < 0.001 4.29 1, 35 0.046 1.59 4, 137 0.18 
Flavor 2.88 4, 137 0.03 1.21 1, 35 0.29 4.31 4, 137 0.003 
Note. DF is degrees of freedom; ACP is Acute Cigarette Perception   
 
Menthol preference significantly moderated the relationship between nicotine condition 
and the difference in ACP composite sensory response, F(1, 137) = 2.66, p = 0.04. Illustrated in 
Figure 12, the magnitude of difference in the ACP composite score increased across contents for 
non-menthol smokers yet was flat for contents ≤11.2 mg/g in menthol smokers. Among non-
menthol smokers, the magnitude of difference in ACP was significantly greater for the 17.4 and 
11.2 mg/g contents vs. contents ≤ 5.5 mg/g; contents 17.4 and 11.2 mg/g were not significantly 
different. For menthol smokers, the magnitude of difference in ACP responding for the 17.4 mg/g 
content was significantly greater than all other contents, except 5.5 mg/g.  
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Figure 12 Mean difference (NIC-VLNC) in ACP composite response by menthol preference and nicotine 
content condition. Bars represent 95% confidence intervals. 
 
There was a significant main effect of menthol preference for ‘Strong’, F(1, 35) = 4.29, p 
= 0.046. As shown in Figure 13, the magnitude of difference between the VLNC and higher 
nicotine content cigarette was smaller for menthol versus non-menthol smokers, across nicotine 
conditions. However, the interaction of menthol by nicotine content condition was not significant, 
F(4, 137) = 1.59, p = 0.18. 
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Figure 13 Mean difference (NIC-VLNC) in ‘Strong’ response by menthol preference and nicotine content 
condition. Bars represent 95% confidence intervals. 
 
For ‘Flavor’, the main effect of menthol preference was not significant, F(1, 35) = 1.21, p 
= 0.28, but there was a significant interaction of menthol by nicotine content condition, F(4, 137) 
= 4.31, p = 0.003. Inspection of Figure 14 shows a steady increase in the magnitude of difference 
in ‘Flavor’ as nicotine content increases for non-menthol—but not menthol—smokers. For non-
menthol smokers, contents ≥5.5 mg/g were rated as having significantly higher ‘Flavor’ than 
VLNC and the magnitude of difference was significantly greater for all contents ≥ 5.5 vs ≤ 2.3 
mg/g. For menthol smokers, only contents 2.3 and 17.4 mg/g were rated as having significantly 
more ‘Flavor’ than the VLNC cigarette, with no significant pairwise differences among nicotine 
content pairs. 
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Figure 14 Mean difference (NIC-VLNC) in ‘Flavor’ response by menthol preference and nicotine content 
condition. Bars represent 95% confidence intervals. 
 
For the analysis testing the effects of ethnicity on the relationship between the ACP 
composite variable and nicotine condition, there was no main effect of ethnicity, F(1, 31) = 2.71, 
p = 0.11, and no interaction of ethnicity and nicotine condition, F(4, 121) = 0.95, p = 0.44. 
Estimated mean difference in ACP by nicotine condition and ethnicity is shown in Figure 15.  
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Figure 15 Mean difference (NIC-VLNC) in ACP composite response by ethnicity and nicotine content 
condition. Bars represent 95% confidence intervals. 
3.4.3  Mediation analysis 
Difference in the composite ACP measure (NIC – VLNC) was examined as a potential 
mechanism underlying the relationship between nicotine content condition and choice behavior 
using mediation analysis. Results of the mediation model are presented in Table 6. ACP composite 
ratings significantly mediated the relationship between nicotine content condition and puff 
choice—indirect effect: a*b = 0.43, 95% CI [0.21, 0.69], p = 0.0005. In sum, nicotine content 
condition influenced puff choice because as the nicotine content increased across conditions, 
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cigarettes with higher nicotine contents had increasingly larger acute positive sensory ratings (i.e., 
ACP) which led to more choices for that higher nicotine content cigarette. 
 
Table 6 Results of the mediation analysis 
 
Direct and indirect effects 
 95% CI 
Path B LL UL 
a ACP on Nicotine Condition 4.48***  2.31 6.64 
b Number of NIC puffs 0.10***  0.07 0.13 
c NIC Puffs on Nicotine Condition 0.07 -0.33 0.47 
a*b Indirect effect: NIC Puffs on Nicotine Condition via ACP 0.43*** 0.21 0.69 
Note. B is beta; CI is confidence interval; LL is lower limit; UL is upper limit; ***p<.001, 
**p<.01, *p<.05. 
 
3.4.4  Moderated mediation analysis 
Moderated mediation analysis was run to determine whether menthol preference affected 
how the relationship between nicotine content condition and ACP composite explained puff 
choice. The goal of this analysis was to test the index of moderated mediation (i.e., the product of 
the interaction effect of menthol by nicotine content condition predicting the moderator and the 
effect of the moderator predicting puff choice).  
Results of the moderated mediation model are presented in Table 7 and an illustration of 
the statistical model is presented in Figure 16 to ease interpretation. The indirect effect of ACP in 
the analysis of puff choice regressed on the Menthol by Nicotine Content Condition interaction 
was not significant, indicating that there was no moderated mediation—indirect effect: a3*b = -
0.38, 95% CI [-0.83, 0.01], p > 0.05. In other words, ACP’s mediation of the relationship between 
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nicotine content condition and choice behavior did not vary between menthol and non-menthol 
smokers. 
 
Table 7 Results of the moderated mediation analysis 
 
Direct and indirect effects 
 95% CI 
Path B LL UL 
a1 ACP on Nicotine Condition 6.64*** 3.53 9.75 
a2 ACP on Menthol (Non-Menthol = 0, Menthol = 1) -3.27 -11.23 4.70 
a3 ACP on Menthol x Nicotine Condition -3.92 -8.12 0.28 
b NIC Puffs on ACP 0.10*** 0.07 0.13 
c NIC Puffs on Nicotine Condition 0.07 -0.33 0.47 
a1*b Indirect effect: NIC Puffs on Nicotine Condition via ACP 0.64*** 0.32 1.03 
a3*b Indirect effect: NIC Puffs on Menthol x Nicotine Condition via ACP -0.38 -0.83 0.01 
Note. B is beta; CI is confidence interval; LL is lower limit; UL is upper limit; ***p<.001 
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Figure 16 Illustration of the statistical model for moderated mediation analysis. Boxes represent variables 
entered into the model; lines represent effects, with arrows pointing towards the predicted variable. Path a1 is 
the effect of the mediator (M) regressed on the independent variable (X); Path a2 is the effect of the mediator 
(M) regressed on the moderator variable (W); Path a3 is the effect of the mediator (M) regressed on the 
interaction of the independent and moderator variables (X*W); Path b is the effect of the dependent variable 
(Y) regressed on the mediator variable (M); Path c´ is the effect of the dependent variable (Y) regressed on 
the independent variable (X). 
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3.5 Aim 3 Analysis 
3.5.1  Likelihood of meeting the 12 out of 16 puff criterion 
This analysis sought to test how much of a nicotine reduction is needed from the 17.4 mg/g 
dose to see a decline in the likelihood of reliably self-administering the NIC dose significantly 
greater than the VLNC, using an a priori binomial distribution criterion: ≥12 NIC choices. 
Estimated percent of the sample choosing the higher nicotine content cigarette at each nicotine 
content condition and results of the analysis are presented in Table 8. Overall, there was a marginal 
main effect of nicotine condition on the likelihood of meeting the 12 out of 16 puff criterion, F(4, 
176) = 2.13, p = 0.08.  
 
Table 8 Results of the binominal logistic mixed model analysis 
Nicotine 
Condition 
Estimated 
Percent ≥12 
NIC Choices 
  95% CI   95% CI 
 B LL UL  OR LL UL 
1.3 mg/g 27.01%  -1.16 -2.30 -0.02  0.31* 0.10 0.98 
2.3 mg/g 20.66%  -1.51 -2.68 -0.34  0.22** 0.07 0.71 
5.5 mg/g 37.84%  -0.66 -1.78 0.46  0.52 0.17 1.59 
11.2 mg/g 46.24%  -0.31 -1.42 0.79  0.73 0.24 2.21 
17.4 mg/g 54.07%  — — —  1.00 — — 
Note. NIC is the higher nicotine content cigarette; B is beta; CI is confidence 
interval; LL is lower limit; UL is upper limit; OR is odds ratio; * p < .05, ** p < 
.01 for difference relative to 17.4 mg/g group. 
 
Additional post hoc exploratory analyses separately assessed the moderating effects of 
menthol preference and ethnicity (Caucasian vs. African American/Black). For ethnicity, there 
were no significant effects—F’s <1.52, p’s > 0.20. For menthol, there was no significant main 
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effect of menthol preference nor a significant interaction of menthol preference by nicotine 
condition, F(1,171) = 0.01, p = 0.94 and F(4, 171) = 1.61, p = 0.17, respectively. The main effect 
of nicotine condition was significant when these additional factors were included in the model, 
F(4, 171) = 2.43, p = 0.049.  
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4.0 Discussion 
The FDA has considered reducing the maximum allowable nicotine content in cigarettes 
to make it easier for established smokers to quit (Benowitz & Henningfield, 1994, 2013, 2018; 
FDA, 2018). A large-scale longitudinal clinical trial—designed to inform potential policy—
identified the reduction in nicotine from a standard nicotine content (15.8 mg/g) needed to 
significantly reduce cigarette consumption (Donny et al., 2015). The primary aim of the current 
study was to validate use of a shorter—potentially more efficient—within-subjects forced-choice 
procedure in identifying the nicotine content reduction needed to reduce relative reinforcement 
(used here as an index of self-administration behavior). Successful validation of this procedure 
would show consistency with the primary outcome from Donny et al. (2015)—significant 
reductions in choice between cigarettes containing ≥5.5 mg/g and those ≤2.3 mg/g. Results from 
the forced-choice procedure were complemented by data on sensory perceptions of acute use of 
the research cigarettes to further examine mechanisms underlying changes in forced-choice 
behavior across nicotine content conditions.  
Overall, the pattern of results from the current forced-choice procedure were not consistent 
with those of Donny et al. (2015). In retrospect, it seems that the different approaches (i.e., within-
subjects testing of acute relative reinforcement vs. randomized between-subjects testing of 
smoking reduction due to extended use) were assessing divergent constructs. Rather than 
observing significantly greater NIC choices for all contents ≥5.5 mg/g vs. ≤2.3 mg/g (the pattern 
observed in Donny et al.), only the 17.4 mg/g condition had significantly greater NIC choices than 
both conditions ≤2.3 mg/g. Potential reasons for the lack of concordance between the current study 
and Donny et al. include methodological differences (e.g., within-subjects vs. between-subjects 
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designs, acute vs. extended use, relative vs. absolute reinforcement, etc.; see section 4.1 Strengths 
and Limitations) and confounding due to menthol preference and/or ethnicity (African 
American/Black or Caucasian).  
The number of NIC choices increased linearly across nicotine conditions for non-menthol 
smokers but was flat across nicotine conditions for menthol smokers. Neither outcome (linear or 
flat across nicotine conditions) nor the presence of moderating effects of menthol (and/or ethnicity) 
are consistent with the pattern of results from Donny et al. (2015). Discussed in greater detail 
below, it is important to note that ethnic homogeneity within menthol preference groups made it 
unclear whether the menthol group differences in choice were actually ethnicity effects. Together, 
these results do not validate use of outcomes from the current within-subjects forced choice 
procedure to predict results of longer clinical trial research—changes in acute relative 
reinforcement due to differences in nicotine content in cigarettes did not align with patterns of self-
administration of cigarettes differing in nicotine content over six-weeks of use. 
Although the current procedure was not able to produce a pattern of results consistent with 
Donny et al. (2015), findings indicate that relative reinforcement was sensitive to changes in 
nicotine content. Overall, each higher nicotine content cigarette was chosen significantly more 
than the 0.4 mg/g alternative, similar to results from Higgins et al. (2017). Unlike Higgins et al., 
there was a threshold for relative reinforcement—choice for the 17.4 mg/g cigarette was 
significantly greater than contents ≤ 2.3 mg/g, suggesting that reducing nicotine content in 
cigarettes to levels ≤ 2.3 mg/g may diminish reinforcement from these cigarettes (relative to a 
conventional nicotine content cigarette).  
It is unclear whether reductions in acute relative reinforcement observed in the lab would 
translate to fewer cigarettes smoked over longer periods of time in the real world. Results of a 
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recent trial by Hatsukami et al. (2018) offer initial support for potential translation. In their 20-
week long study, Hatsukami and colleagues randomized smokers to one of three groups: 1) use 
cigarettes gradually declining in nicotine content (15.5, 11.7, 5.2 2.4, 0.4 mg/g; four weeks per 
content); 2) use only cigarettes containing 15.5 mg/g; or 3) use only cigarettes containing 0.4 mg/g. 
At the end of the study, participants in the gradual reduction group smoked a similar number of 
cigarettes per day as those randomized to the 15.5 mg/g control condition, but reduced cigarette 
consumption (to a non-significant degree) during the 2.4 and 0.4 mg/g conditions. Those 
randomized to exclusively use the 0.4 mg/g over the entire 20-week study smoked significantly 
fewer cigarettes per day than those in both the gradual reduction and control conditions. In the 
current study, choice of cigarettes ≤2.4 mg/g were significantly lower than choice for the 17.4 
mg/g condition and all nicotine contents were chosen significantly greater than the 0.4 mg/g 
alternative. Taken together, policy reducing the maximum allowable nicotine content in cigarettes 
to 0.4 mg/g may lead to a reduction in smoking. Given the continued—albeit reduced—smoking 
of cigarettes ≤2.4 mg/g observed in extended use trials (Donny et al., 2011, 2015; Hatsukami et 
al., 2018), it is likely that smokers will continue to use cigarettes containing 2.4 mg/g despite a 
reduction in reinforcement from nicotine per se.   
Post hoc exploratory analyses assessed differential patterns in choice across nicotine 
contents due to sex, menthol preference, and ethnicity. Men and women chose similarly across 
nicotine content conditions—sex did not significantly moderate the relationship between nicotine 
condition and choice behavior. This lack of sex differences was not surprising, despite the well-
established sex differences in nicotine reinforcement showing that women are generally less 
sensitive to changes in nicotine than men (Perkins, 2008; Pogun, Yararbas, Nesil, & Kanit, 2017). 
This study was not originally designed nor powered to detect any between-group differences, and 
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so it is likely that the small sample size led to an underpowered analysis of sex differences. 
Additional research in larger samples would be needed to better examine sex differences in acute 
relative reinforcing effects of SPECTRUM cigarettes differing in nicotine content. 
Menthol preference moderated choice behavior across nicotine content conditions. 
Looking at each of these subgroups separately, choice results for non-menthol smokers followed 
a linear dose response with increases in NIC choices as nicotine content also increased. However, 
choice behavior for menthol smokers across nicotine contents was much more erratic, with no dose 
response effect. Together, these results initially suggest that non-menthol smokers may have been 
more sensitive to changes in nicotine content of these SPECTRUM cigarettes than menthol 
smokers, subject to the limitations of this study procedure. However, ethnic homogeneity within 
menthol preference groups (Caucasian within non-menthol and African American/Black within 
menthol) makes it difficult to separate effects due to menthol preference vs. ethnicity.  
A series of exploratory post hoc analyses attempting to parse menthol from ethnicity were 
largely inconclusive. As with menthol preference, there was a significant interaction between 
ethnicity (Caucasian vs. African American/Black) and nicotine condition. Caucasians had a mostly 
linear increase in choice across nicotine contents and choice among African American/Black did 
not have a perceptible pattern—consistent with the patterns of choice for non-menthol and menthol 
smokers, respectively. Follow-up analyses comparing menthol preference within Caucasians and 
ethnicity within menthol smokers did not clarify the situation (most likely due to underpowered 
analyses among small subgroups of smokers). Within Caucasian smokers, there appeared to be a 
linear increase in choice for non-menthol and a zig-zag pattern for menthol smokers, but none of 
the menthol effects were significant. Among menthol smokers, there were no differences in choice 
between Caucasian and African American/Black participants. In sum, it is unclear whether the 
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menthol effects on choice behavior were due to ethnicity. Further research in a larger sample with 
ethnic heterogeneity within menthol preference groups is needed to better understand whether 
menthol preference, ethnicity, or a combination of these factors differentially influences acute 
relative reinforcement from cigarettes varying in nicotine content. 
Acute sensory perceptions were found to vary across the range of nicotine content 
conditions. Overall, there was a significant main effect of nicotine content condition for each 
measure of pleasurable sensory perceptions of smoking—the magnitude of difference in sensory 
ratings between the NIC and VLNC cigarettes increased across doses, consistent with earlier 
research on sensory perceptions of acute RNC cigarette use (Arger et al, 2017; Bergeria et al., 
2019; Cassidy et al., 2018a, 2018b, 2019; Faulkner et al., 2017, 2018; Hatsukami et al., 2013; 
Streck et al., 2019). In sum, these data confirm the notion that a cigarette’s nicotine level increases 
its immediate acute pleasurable subjective effects.  
A particularly novel contribution of this research is the finding that the composite of acute 
subjective perceptions significantly mediated the relationship between nicotine content condition 
and forced-choice behavior. Increases in nicotine content led to more choices for the higher 
nicotine content cigarette because higher nicotine content cigarettes elicited a greater magnitude 
of difference in acute pleasurable subjective effects vs. the VLNC cigarette, and smokers preferred 
the cigarette providing more pleasurable subjective effects. This mediation process did not vary 
due to menthol preference, showing that ACP mediated forced-choice responding equally among 
menthol groups, despite menthol’s blunting of sensory perceptions. The relationship between ACP 
and choice is consistent with previous research relating pleasurable sensory perceptions to choice 
of cigarettes containing 0.4 and 16-17 mg/g (Perkins, Karelitz, & Kunkle, 2018), but extend those 
findings to examine these associations across narrower differences in nicotine contents. Other 
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research in a sample of smokers “vulnerable to nicotine addiction” reported similar results, with 
pleasurable sensory perceptions predicting increased operant responding to earn higher nicotine 
content cigarettes when presented concurrently with the opportunity to also earn a lower content 
cigarette (Bergeria et al., 2019). Altogether, these results substantially document that acute 
pleasurable subjective perceptions constitute one of the mechanisms underlying relative 
reinforcing effects of smoking nicotine.  
Unlike the indistinguishable effects of menthol and ethnicity on choice behavior, 
pleasurable sensory perceptions of smoking across nicotine conditions were found to differ due to 
menthol preference but not ethnicity. As menthol is a flavoring added to cigarettes, it is not 
unexpected that it would be found to alter sensory perceptions of smoking. Nicotine and menthol 
provide unique, qualitatively different sensory aspects when smoking, which can come to reinforce 
smoking behavior through associative learning mechanisms (Ahijevych & Garrett, 2010). In 
unmentholated cigarettes, higher levels of nicotine are associated with greater “throat hit” or 
“scratch”, which can be pleasing to non-menthol, but not menthol smokers (Kreslake, Wayne, & 
Connolly, 2007; Wayne & Connolly, 2004). Menthol provides a reinforcing cooling sensation 
which reduces throat scratch and ameliorates smoke-related irritation (Kreslake, Wayne, & 
Connolly, 2007; Wayne & Connolly, 2004). In the context of the current study, mentholated 
cigarettes provided significantly different patterns of pleasurable perceptions of smoking 
compared to non-mentholated cigarettes.  
There were linear increases for the difference in ACP composite (NIC – VLNC) for non-
menthol smokers across nicotine conditions, indicating greater pleasurable responses as the 
nicotine content of the higher content cigarette increased. For menthol smokers, the difference in 
ACP composite was flat across contents ≤11.2 mg/g, but significantly increased for 17.4 mg/g. 
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This suggests that menthol may have blunted pleasurable sensory perceptions of cigarettes < 17.4 
mg/g. Earlier research from our lab using a larger sample failed to find differences due to menthol 
preference on ACP composite ratings of cigarettes containing 0.4 and 16-17 mg/g of nicotine 
(Perkins, Karelitz, & Kunkle, 2018). The current menthol-related differences in ACP are due to 
assessing a wider range of nicotine contents; differences would not have emerged looking at only 
the 17.4 mg/g condition in the present study.   
Menthol smokers rated the SPECTRUM cigarettes as less strong compared to non-menthol 
smokers across all nicotine contents, consistent with earlier research and the notion that menthol 
has analgesic effects (Davis, 2017; Hatsukami et al., 2013). Menthol smokers’ subjective rating of 
‘Strong’ may be related to the cigarette’s menthol content (Kreslake, Wayne, & Connolly, 2007; 
Wayne & Connolly, 2004). In the current study, menthol contents of the SPECTRUM cigarettes 
ranged 0.91-2.08 mg/g, consistent with levels needed to experience a “slight menthol sensory 
effect” (Ai et al., 2016). In contrast, menthol contents of participants’ self-reported brands are 
much higher (4.98-5.40 mg/cigarette), at or above levels needed for a “strong menthol effect” (i.e., 
2.5-4.5 mg/g or 1.75-3.40 mg/cigarette; Ai et al., 2016). It is possible that the relatively lower 
menthol contents in the SPECTRUM cigarettes may have blunted ‘Strong’ ratings—as this can be 
an index of menthol flavoring for menthol smokers—but this would need to be directly confirmed 
in additional research. 
Ratings of ‘Flavor’ varied between menthol and non-menthol smokers as a function of 
nicotine content condition—non-menthol smokers had orderly dose response increases in ‘Flavor’, 
but menthol smokers’ ratings did not vary across nicotine content conditions. As with ‘Strong’, 
non-menthol and menthol smokers have disparate qualitative associations for a cigarette’s ‘Flavor’ 
or ‘Taste’. For non-menthol smokers, ‘Flavor’ or ‘Taste’ is related to throat impact and 
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astringency, whereas menthol smokers associate smoke concentration and added flavors 
(Kreslake, Wayne, & Connolly, 2007). Notably, the nicotine condition with the lowest menthol 
content (11.2 mg/g nicotine, 0.91 mg/g menthol) was not chosen significantly greater than the 
VLNC and had the smallest magnitude of difference in ‘Flavor’, relative to the VLNC cigarette 
(0.4 mg/g nicotine, 1.08 mg/g menthol). Earlier research assessing menthol smokers’ responses to 
non-mentholated cigarettes found that menthol smokers perceive lower levels of ‘Flavor’ in non-
menthol vs. menthol cigarettes when all other cigarette-related factors were completely matched 
(Strasser et al., 2013). It is possible that menthol smokers’ lower ratings of ‘Flavor’ across nicotine 
contents in the current study could have been due to changes in menthol content, consistent with 
Strasser et al. (2013). Because menthol and nicotine contents were not manipulated independently 
in the present study, it is not possible to separate effects due to changes in just one of these factors.  
Beyond possible cigarette-level explanations, individual differences may have also 
contributed to the observed variability between menthol and non-menthol preferring groups. 
Menthol smokers have been shown to have nicotine metabolite ratios consistent with slower 
nicotine clearance rates, which extends nicotine exposure from each cigarette (Alsharari et al., 
2015; DeVito et al., 2016; Fagan et al., 2016). Unfortunately, nicotine metabolite ratios were not 
measured in the current study and earlier studies assessing the effect of nicotine metabolite ratio 
on smoking reduced nicotine content cigarettes were exclusively of non-menthol smokers 
(Bandiera et al., 2015; Faulkner et al., 2017; Mercincavage at el., 2018). Additional research may 
be needed to collectively assess the effects of nicotine content, menthol preference, ethnicity, and 
nicotine metabolite ratio on relative reinforcement of nicotine via tobacco smoke. 
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4.1 Strengths and Limitations  
Results of the study must be interpreted within the context of the strengths and weaknesses 
of its design. The methods and measures of self-administration were different between the current 
study and Donny et al. (2015). Whereas Donny et al. (2015) assessed between-subjects effects on 
daily smoking self-administration (i.e. absolute reinforcing effects) of each nicotine content 
condition, the present study tested within-subjects effects of preference (relative reinforcement) 
between each content vs. the 0.4 mg/g VLNC. Use of a within-subjects design allowed for a 
smaller sample size, as each participant acted as their own control increasing statistical power 
(Cohen, 1988). Further, Donny et al. (2015) studied smokers in their natural environment over 
weeks of use; this type of ecological validity was lost in the lab-based study of acute self-
administration. Likely due to these methodological differences, the pattern of results in acute 
relative reinforcement from the current study were not consistent with the earlier longitudinal dose-
response effects on absolute reinforcement. 
The final sample size (n=37) was smaller than what was originally proposed (and 
committee-approved, n=40). Although there was a significant main effect for the primary analysis 
of choice behavior across nicotine conditions, many of the exploratory subgroup analyses were 
underpowered and small cell sizes prevented further probing from yielding useful results. In other 
words, interesting results emerged (e.g., menthol preference moderating choice across nicotine 
content conditions), but the small sample size prevented further exploration to better understand 
the outcomes and implications (e.g., inability to distinguish menthol preference effects from 
ethnicity effects). Future research intending to examine differences among subgroups of smokers 
will need to have much larger sample sizes than what was originally proposed for the current study. 
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There was not enough time between each 4-puff smoking trial for complete clearance of 
the nicotine consumed in prior trials (the elimination half-life of nicotine in humans is about 2 hrs; 
Benowitz, 1988, 1996). The fixed order of the exposure trials (VLNC, NIC, NIC, VLNC) was 
designed to minimize carryover for the initial sampling of each cigarette while also providing 
adequate exposure to each to inform subsequent choice. Prior research has shown that differences 
between cigarettes varying in nicotine content are enhanced when compared concurrently versus 
independent testing sessions (Perkins et al., 2002). Concurrent presentation of cigarettes within 
each session of the current study likely increased sensitivity to differences between each pair, 
rather than attenuate such differences as would be expected had carryover effects occurred. 
Similarly, analyses showed no effects of trial on measures, further discounting possible carryover 
effects. 
The choice options did not include a true placebo cigarette (i.e., 0 mg/g) for comparison, 
requiring all higher nicotine content cigarettes to be compared with one containing some, if 
minimal (0.4 mg/g), nicotine. This is different from earlier nicotine self-administration studies 
using other methods of delivery (i.e., IV infusion, nasal spray, transdermal patch), which are not 
limited to non-zero nicotine comparison levels. Smoking reduced nicotine content or 
“denicotinized” cigarettes (i.e., Quest 3 with 1.0 mg/g nicotine content) results in “substantial” 
nicotinic receptor occupancy, but at rates lower than a cigarette containing a moderate level of 
nicotine (Quest 1, 12.5 mg/g; Brody et al., 2009; FDA, 2018). Thus, RNC cigarettes can still 
deliver nicotine to the user’s brain, which may combine with non-nicotine (i.e., secondary) 
reinforcing effects to promote use of these products (Rose, Salley, Behm, Bates, & Westman, 
2010). Consistent with this idea, studies have shown that smokers will continue to smoke RNC 
cigarettes over extended periods of time (Donny et al., 2006, 2009, 2015; Hatsukami et al., 2018; 
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Smith et al., 2019), suggesting that these cigarettes are still able to reinforce smoking behavior. 
Taken together, nicotine and non-nicotine factors of smoking the VLNC comparison cigarette may 
have provided some degree of reinforcement to participants in the current study, meaning that 
comparisons between the VLNC and higher nicotine content cigarettes did not isolate the 
reinforcing effects of nicotine per se. However, 0.4 mg/g is the lowest technically feasible nicotine 
content for RNC cigarettes currently available (World Health Organization, 2015) and thus the 
lowest comparison cigarette possible.  
The total number of puffs per each 2.5- to 3-hour session (16 exposure puffs and 16 forced 
choice puffs; 32 total puffs or ~3 full cigarettes) were generally consistent with the typical smoker 
who smokes multiple cigarettes in the hours after waking in the morning (Allen, Mooney, 
Chakraborty, & Allen, 2009; Mooney, Green, & Hatsukami, 2006). Most of the cigarettes 
contained low levels of nicotine, further limiting the likelihood of nicotine satiation, let alone 
toxicity. Half of the 16 exposure puffs were from the 0.4 mg/g VLNC cigarette and the remaining 
puffs during the choice trials were chosen by the participant, limiting total nicotine exposure by 
design. Moreover, no significant effect of trial, as mentioned previously, further rules out evidence 
of satiation or toxicity.  
Requiring participants to rate each cigarette immediately following each exposure trial may 
have influenced later choice behavior due to a phenomenon known as “verbal overshadowing”. 
Verbal overshadowing occurs when using words to describe an inherently internal non-verbal 
experience—the verbal representation may not accurately reflect what was experienced (Creswell, 
Sayette, Schooler, Wright, & Pacilio, 2018; Schooler, 2002). Non-verbal assessment of sensory 
perceptions (such as the visceral dynamometer used in Creswell et al. [2018, 2019]) could be used 
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in future research to assess whether verbal, non-verbal, or no assessment of perceptions of acute 
smoking affect subsequent choice behavior. 
Participants engaged in a 15-min computer task unrelated to the current study’s aims after 
three of the four exposure trials (but none occurred once forced-choice trials began). It is unlikely 
that working on the computer task between exposure trials affected choice behavior during the 
subsequent choice trials. Nevertheless, there is no way to know whether this additional unrelated 
task influenced outcomes in the current study. It would be ideal for future studies aiming to assess 
changes in acute relative reinforcement due to differences in nicotine content to not include tasks 
unrelated to the main research question. 
Finally, the influence of non-conscious motivations underlying choice behavior was not 
assessed. Broadly, cognitive factors outside of conscious awareness can influence behavior and 
have been incorporated into many theories on drug dependence and abuse (e.g., Baker et al., 2004; 
Robinson & Berridge, 1993; Tiffany, 1990). By design, the forced-choice paradigm eliminated the 
participant’s need to decide on whether to take a puff, they only needed to choose which cigarette 
to take a puff from (which was found to be mediated by participants’ conscious assessment of the 
cigarette’s immediate acute pleasurable subjective effects). Non-conscious motivations would be 
more likely to influence choice in a free-choice paradigm where participants have the option to 
abstain and would need to be taken into consideration when designing such studies (e.g., Higgins 
et al., 2017).  
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4.2 Implications and Future Directions 
Despite its general lack of predictive validity in comparison to the Donny et al. (2015) trial 
results, results of the current study may still have useful implications for informing other research 
intended to address nicotine reduction policy. The forced-choice procedure was sensitive to 
differences in relative-reinforcement due to changes in nicotine content in cigarettes, resulting in 
reduced relative reinforcement for contents ≤2.4 vs 17.4 mg/g. However, each higher nicotine 
content cigarette was chosen significantly more than the 0.4 mg/g VLNC alternative, suggesting 
that setting 0.4 mg/g as the maximum allowable nicotine content could lead to the greatest 
reduction in nicotine reinforcement overall.  
The forced choice procedure may be used in future research of novel nicotine delivery 
methods—assessing changes in acute relative reinforcement due to changes in nicotine content per 
se among different versions of the same product (e.g., electronic cigarettes, heat-not-burn tobacco 
products, etc.). Use of this procedure may also be extended to testing differences in choice due to 
nicotine content per se in approved NRT medications (e.g., inhaler, gum, lozenge, etc.) as well as 
novel products of unknown abuse liability (e.g., “Voke” a “vaporless valve technology inhaler”; 
https://www.voke.com/).  
 Finally, the forced choice procedure may be used to assess changes in preference of 
nicotine products following application of novel cessation interventions or pre-treatment with 
novel medications. This approach could be used to initially test cross-species translation of 
preclinical self-administration research of changes in nicotine reinforcement following pre-
treatment with a novel medication. Although this approach may have limited clinical implications, 
it could provide initial information on the efficacy of those prospective interventions for reducing 
reinforcement from nicotine. 
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